IMAX (IMAX) 10-Q25 Apr 242024 Q1 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2024 shares
Document Information [Line Items]
Entity Registrant Name	IMAX Corporation
Entity Central Index Key	0000921582
Document Type	10-Q
Document Period End Date	Mar. 31, 2024
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock Shares Outstanding	52,622,200
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	Z4
Title of 12(b) Security	Common Shares, no par value
Trading Symbol	IMAX
Security Exchange Name	NYSE
Entity File Number	001-35066
Entity Tax Identification Number	98-0140269
Entity Address, Address Line One	2525 Speakman Drive
Entity Address, City or Town	Mississauga
Entity Address, State or Province	ON
Entity Address, Country	CA
Entity Address, Postal Zip Code	L5K 1B1
City Area Code	(905)
Local Phone Number	403-6457
Other Address [Member]
Document Information [Line Items]
Entity Address, Address Line One	902 Broadway, Floor 20
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Country	US
Entity Address, Postal Zip Code	10010
City Area Code	(212)
Local Phone Number	821-0142

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 81,017	$ 76,200
Accounts receivable, net of allowance for credit losses	140,579	136,259
Financing receivables, net of allowance for credit losses	125,614	127,154
Variable consideration receivables, net of allowance for credit losses	64,503	64,338
Inventories	36,153	31,584
Prepaid expenses	12,711	12,345
Film assets, net of accumulated amortization	8,050	6,786
Property, plant and equipment, net of accumulated depreciation	240,450	243,299
Other assets	19,634	20,879
Deferred income tax assets, net of valuation allowance	7,712	7,988
Goodwill	52,815	52,815
Other intangible assets, net of accumulated amortization	34,902	35,022
Total assets	824,140	814,669
Liabilities
Accounts payable	18,734	26,386
Accrued and other liabilities	101,038	111,013
Deferred revenue	60,999	67,105
Revolving credit facility borrowings, net of unamortized debt issuance costs	68,034	22,924
Convertible Notes and other borrowings, net of unamortized discounts and debt issuance costs	229,435	229,131
Deferred income tax liabilities	12,521	12,521
Total liabilities	490,761	469,080
Commitments, contingencies and guarantees (see Note 7)
Non-controlling interests
Non-controlling interests	649	658
Shareholders' equity
Capital stock common shares - no par value. Authorized - unlimited number. 52,622,200 issued and outstanding (December 31, 2023 - 53,260,276 issued and outstanding)	393,597	389,048
Other equity	171,877	185,087
Statutory surplus reserve	3,932	3,932
Accumulated deficit	(297,284)	(292,845)
Accumulated other comprehensive loss	(13,320)	(12,081)
Total shareholders' equity attributable to common shareholders	258,802	273,141
Non-controlling interests	73,928	71,790
Total shareholders' equity	332,730	344,931
Total liabilities and shareholders' equity	$ 824,140	$ 814,669

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Shareholders' equity
Common stock, par value	$ 0	$ 0
Common stock, shares issued	52,622,200	53,260,276
Common stock, shares outstanding	52,622,200	53,260,276

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Revenues, total	$ 79,123,000	$ 86,946,000
Costs and expenses applicable to revenues
Cost and expenses applicable to revenues, total	32,234,000	36,895,000
Gross margin	46,889,000	50,051,000
Selling, general and administrative expenses	31,257,000	34,148,000
Research and development	2,187,000	1,855,000
Amortization of intangible assets	1,343,000	1,074,000
Credit loss expense, net	35,000	220,000
Restructuring and executive transition costs	0	1,353,000
Income from operations	12,067,000	11,401,000
Realized and unrealized investment gains	30,000	44,000
Retirement benefits non-service expense	(107,000)	(77,000)
Interest income	534,000	407,000
Interest expense	(1,945,000)	(1,767,000)
Income before taxes	10,579,000	10,008,000
Income tax expense	(5,159,000)	(4,885,000)
Net income	5,420,000	5,123,000
Net income attributable to non-controlling interests	(2,146,000)	(2,669,000)
Net income attributable to common shareholders	$ 3,274,000	$ 2,454,000
Net income per share attributable to common shareholders - basic and diluted:
Net income per share - basic	$ 0.06	$ 0.05
Net income per share - diluted	$ 0.06	$ 0.04
Weighted average shares outstanding - basic	52,501	54,064
Weighted average shares outstanding - diluted	53,406	54,991
Technology Sales [Member]
Revenues
Revenues, total	$ 7,904,000	$ 17,822,000
Costs and expenses applicable to revenues
Cost and expenses applicable to revenues, total	4,767,000	7,232,000
Image Enhancement and Maintenance Services [Member]
Revenues
Revenues, total	50,348,000	47,127,000
Costs and expenses applicable to revenues
Cost and expenses applicable to revenues, total	21,195,000	23,085,000
Technology Rentals [Member]
Revenues
Revenues, total	18,601,000	6,578,000
Costs and expenses applicable to revenues
Cost and expenses applicable to revenues, total	6,272,000	20,058,000
Finance Income [Member]
Revenues
Revenues, total	$ 2,270,000	$ 1,939,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 5,420	$ 5,123
Other comprehensive (loss) income, before tax
Unrealized net (loss) gain from cash flow hedging instruments	(916)	134
Realized net loss from cash flow hedging instruments	11	339
Foreign currency translation adjustments	(542)	2,440
Defined benefit and postretirement benefit plans	(249)	(176)
Total other comprehensive (loss) income, before tax	(1,696)	2,737
Income tax benefit (expense) related to other comprehensive (loss) income	303	(78)
Other comprehensive income (loss), net of tax	(1,393)	2,659
Comprehensive income	4,027	7,782
Comprehensive income attributable to non-controlling interests	(1,992)	(3,358)
Comprehensive income attributable to common shareholders	$ 2,035	$ 4,424

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net income	$ 5,420	$ 5,123
Adjustments to reconcile net income to cash (used in) provided by operating activities:
Depreciation and amortization	15,164	13,320
Amortization of deferred financing costs	492	625
Credit loss expense, net	35	220
Write-downs, including asset impairments	109	304
Deferred income tax expense (benefit)	571	(193)
Share-based and other non-cash compensation	4,783	5,135
Unrealized foreign currency exchange loss (gain)	33	(78)
Realized and unrealized investment gains	(30)	(44)
Changes in assets and liabilities:
Accounts receivable	(4,502)	12,374
Inventories	(4,672)	(5,946)
Film assets	(4,912)	(3,884)
Deferred revenue	(6,075)	2,606
Changes in other operating assets and liabilities	(17,384)	(8,344)
Net cash (used in) provided by operating activities	(10,968)	21,218
Investing Activities
Purchase of property, plant and equipment	(1,104)	(364)
Investment in equipment for joint revenue sharing arrangements	(4,442)	(2,157)
Acquisition of other intangible assets	(1,594)	(1,760)
Net cash used in investing activities	(7,140)	(4,281)
Financing Activities
Revolving credit facility borrowings	45,000	25,717
Repayments of revolving credit facility borrowings		(31,180)
Other borrowings		315
Repayment of other borrowings	(156)
Repurchase of common shares	(17,856)	(3,656)
Taxes withheld and paid on employee stock awards vested	(4,194)	(6,233)
Net cash provided by (used in) financing activities	22,794	(15,037)
Effects of exchange rate changes on cash	131	(55)
Increase in cash and cash equivalents during period	4,817	1,845
Cash and cash equivalents, beginning of period	76,200	97,401
Cash and cash equivalents, end of period	$ 81,017	$ 99,246

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Capital Stock [Member]	Other Equity [Member]	Statutory Surplus Reserve [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Non-controlling Interests [Member]
Balance, beginning of period at Dec. 31, 2022		$ 376,715	$ 185,678	$ 3,932	$ (293,124)	$ (9,846)
Balance, beginning of period at Dec. 31, 2022							$ 65,691
Movement of Shareholders' Equity
Amortization of share-based payment expense - stock options			91
Amortization of share-based payment expense - restricted share units			3,314
Amortization of share-based payment expense - performance stock units			1,021
Restricted share units vested		12,676	(19,233)
Net income attributable to common shareholders	$ 2,454				2,454
Common shares repurchased and retired		109			(1,739)
Net income attributable to non-controlling interests	2,669						2,660
Other comprehensive (loss) income, net of tax	2,659					1,970
Other comprehensive (loss) income, net of tax							689
Share-based compensation attributable to non-controlling interests							50
Balance, end of period at Mar. 31, 2023		389,500	170,871	3,932	(292,409)	(7,876)
Balance, end of period at Mar. 31, 2023							69,090
Movement of Shareholders' Equity
Total shareholders' equity	333,108
Total shareholders' equity	344,931
Balance, beginning of period at Dec. 31, 2023	273,141	389,048	185,087	3,932	(292,845)	(12,081)
Balance, beginning of period at Dec. 31, 2023	71,790						71,790
Movement of Shareholders' Equity
Amortization of share-based payment expense - restricted share units			2,924
Amortization of share-based payment expense - performance stock units			1,887
Restricted share units vested		13,066	(17,943)
Net income attributable to common shareholders	3,274				3,274
Common shares repurchased and retired		(8,517)			(7,713)
Net income attributable to non-controlling interests	2,146						2,155
Other comprehensive (loss) income, net of tax	(1,393)					(1,239)
Other comprehensive (loss) income, net of tax							(154)
Share-based compensation attributable to non-controlling interests							59
Change in ownership interest related to IMAX China			(78)				78
Balance, end of period at Mar. 31, 2024	258,802	$ 393,597	$ 171,877	$ 3,932	$ (297,284)	$ (13,320)
Balance, end of period at Mar. 31, 2024	73,928						$ 73,928
Movement of Shareholders' Equity
Total shareholders' equity	$ 332,730

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 3,274	$ 2,454

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. Basis of Presentation Accounting Principles IMAX Corporation, together with its consolidated subsidiaries (the “Company” or “IMAX”), prepares its financial statements in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted from this report, as is permitted by such rules and regulations. In the Company’s opinion, the unaudited Condensed Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. The Condensed Consolidated Balance Sheet at December 31, 2023 was derived from the Company’s audited annual Consolidated Financial Statements, but does not contain all of the footnote disclosures included in the annual financial statements. The interim results presented in the Company’s Condensed Consolidated Statements of Operations are not necessarily indicative of results for a full year. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements included in the Company’s 2023 Annual Report on Form 10-K (the “2023 Form 10-K”), which should be consulted for a summary of the significant accounting policies utilized by the Company. These Condensed Consolidated Financial Statements are prepared following the same accounting policies disclosed in the 2023 Form 10-K. Principles of Consolidation These Condensed Consolidated Financial Statements include the accounts of IMAX Corporation together with its consolidated subsidiaries, except for subsidiaries which have been identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. All intercompany accounts and transactions have been eliminated. The Company has evaluated its various variable interests to determine whether they are VIEs as required by U.S. GAAP. The Company has interests in ten film production companies, which have been identified as VIEs. The Company is the primary beneficiary of and consolidates five of these entities as it has the power to direct the activities that most significantly impact the economic performance of the VIE, and it has the obligation to absorb losses or the right to receive benefits from the respective VIE that could potentially be significant. The majority of the assets relating to these production companies are held by the IMAX Original Film Fund (the “Original Film Fund”) as described in Note 17 (b). The Company does not consolidate the other five film production companies because it does not have the power to direct their activities and it does not have the obligation to absorb the majority of the expected losses or the right to receive expected residual returns. The Company uses the equity method of accounting for these entities, which are not material to the Company’s Condensed Consolidated Financial Statements. A loss in the value of an equity method investment that is other than temporary is recognized as a charge in the Condensed Consolidated Statements of Operations. As of March 31, 2024 and December 31, 2023, total assets and liabilities of the Company’s consolidated VIEs are as follows: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Total assets $ 1,410 $ 1,425 Total liabilities $ 246 $ 246 Estimates and Assumptions In preparing the Company’s Condensed Consolidated Financial Statements, management makes judgments in applying various accounting policies. The areas of policy judgment are consistent with those reported in Note 2(b) of the Company’s audited Consolidated Financial Statements included in its 2023 Form 10-K. Management also considers that its determination of operating and reporting segments represents an area of judgment, and has made this conclusion on the basis of what comprises the discrete financial information produced, but not provided to or used by its Chief Operating Decision Maker (“CODM”) to carry out this function. In addition, management makes assumptions about the Company’s future operating results and cash flows in deriving critical accounting estimates used in preparing the Condensed Consolidated Financial Statements. The significant estimates made by management include, but are not limited to: (i) the allocation of the transaction price in an IMAX System arrangement to distinct performance obligations; (ii) the amount of variable consideration to be earned on sales of IMAX Systems based on projections of future box office performance; (iii) expected credit losses on accounts receivable, financing receivables, and variable consideration receivables; (iv) provisions for the write-down of excess and obsolete inventory; (v) the fair values of the reporting units used in assessing the recoverability of goodwill; (vi) the cash flow projections used in testing the recoverability of long-lived assets such as the system equipment supporting joint revenue sharing arrangements; (vii) the economic lives of the system equipment supporting joint revenue sharing arrangements; (viii) the useful lives of intangible assets; (ix) the ultimate revenue forecasts used to test the recoverability of film assets; (x) the discount rates used to determine the present value of financing receivables and lease liabilities, as well as to determine the fair values of the Company’s reporting units for the purpose of assessing the recoverability of goodwill; (xi) pension plan assumptions; (xii) estimates related to the fair value and projected vesting of share-based payment awards; (xiii) the valuation of deferred income tax assets; and (xiv) reserves related to uncertain tax positions.

New Accounting Standards and Ac

New Accounting Standards and Accounting Changes	3 Months Ended
New Accounting Standards and Accounting Changes	Mar. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards and Accounting Changes	2. New Accounting Standards and Accounting Changes Adoption of New Accounting Standards In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-06, “Disclosure Improvements: Codification Amendments in response to the SEC’s Disclosure Update and Simplification Initiative” (“ASU 2023-06”). ASU 2023-06 incorporates into U.S. GAAP certain presentation and disclosure requirements currently included in the SEC’s regulations. Each amendment will become effective prospectively from the date the SEC withdrawals the corresponding SEC regulatory requirement. The Company adopted ASU 2023-06 on January 1, 2024 . The adoption of ASU 2023-06 did no t have a material impact on the Company’s Consolidated Financial Statements. Recently Issued FASB Accounting Standard Codification Updates Not Yet Adopted In March 2020, the FASB issued Accounting Standards Update No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The purpose of ASU 2020-04 is to provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 is effective for all entities from the beginning of an interim period that includes the issuance date of the ASU 2020-04. In October 2022, the FASB extended the temporary accounting relief to December 31, 2024 from the current sunset date of December 31, 2022. As of March 31, 2024, the Company is not party to any third party contracts that reference the London Interbank Offered Rate (“LIBOR”). Accordingly, the Company does not expect ASU 2020-04 to have a material effect on its Consolidated Financial Statements. In November 2023, the FASB issued Accounting Standards Update No. 2023-07, Segment Reporting (Topic 820): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The purpose of ASU 2023-07 is to enhance the interim disclosure requirements by more closely aligning them with the annual requirements. ASU 2023-07 requires interim and annual disclosures to include information about the company's significant segment expenses. ASU 2023-07 will be effective for the Company’s year ended December 31, 2024 and all interim periods thereafter. The Company is in the process of evaluating the impact of ASU 2023-07 on its financial statements. In December 2023, the FASB issued Accounting Standard Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The amendments in ASU 2023-09 improve the transparency of income tax disclosures by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU 2023-09 will be effective for the Company’s year ended December 31, 2025. The Company is in the process of evaluating the impact of ASU 2023-09 on its financial statements. In March 2024, the FASB issued Accounting Standard Update 2024-01, Compensation - Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”). ASU 2024-01 amends the guidance in Accounting Standard Codification 718 (“ASC 718”) by adding an illustrative example to demonstrate and clarify how to apply the scope guidance to determine whether profits interests and similar awards should be accounted for as share-based payment arrangement under ASC 718 or another standard. ASU 2024-01 will be effective for the Company’s period ended March 31, 2025. The Company is in the process of evaluating the impact of ASU 2024-01 on its financial statements. The Company considers the applicability and impact of all recently issued FASB accounting standard codification updates. Accounting standard updates that are not noted above were assessed and determined to be not applicable or not significant to the Company’s Condensed Consolidated Financial Statements for the period ended March 31, 2024 .

Receivables

Receivables	3 Months Ended
Receivables	Mar. 31, 2024
Receivables [Abstract]
Receivables	3. Receivables The ability of the Company to collect its receivables is principally dependent on the viability and solvency of individual theater operators which is significantly influenced by consumer behavior and general economic conditions. Theater operators, or other customers, may experience financial difficulties that could result in them being unable to fulfill their payment obligations to the Company. In order to mitigate the credit risk associated with its receivables, management performs an initial credit evaluation prior to entering into an arrangement with a customer and then regularly monitors the credit quality of each customer through an analysis of collections history and aging. This monitoring process includes meetings on at least a monthly basis to identify credit concerns and potential changes in credit quality classification. A customer may improve their credit quality classification once a substantial payment is made on an overdue balance or when the customer has agreed to a payment plan and payments have commenced in accordance with that plan. Changes in credit quality classification are dependent upon management approval. The Company’s internal credit quality classifications are as follows: • Good Standing — The theater operator continues to be in good standing as payments and reporting are received on a regular basis. • Credit Watch — The theater operator has demonstrated a delay in payments, but continues to be in active communication with the Company. Theater operators placed on Credit Watch are subject to enhanced monitoring. In addition, depending on the size of the outstanding balance, length of time in arrears, and other factors, future transactions may need to be approved by management. These receivables are in better condition than those in the Pre-Approved Transactions Only category, but are not in as good condition as the receivables in the Good Standing category. • Pre-Approved Transactions Only — The theater operator has demonstrated a delay in payments with little or no communication with the Company. All services and shipments to the theater operator must be reviewed and approved by management. These receivables are in better condition than those in the All Transactions Suspended category, but are not in as good condition as the receivables in the Credit Watch category. In certain situations, a theater operator may be placed on nonaccrual status and all revenue recognition related to the theater may be suspended, including the accretion of Finance Income for Financing Receivables. • All Transactions Suspended — The theater operator is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater operator is classified within the All Transactions Suspended category, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are suspended, including the accretion of Finance Income for Financing Receivables. During the period when the accretion of Finance Income is suspended for Financing Receivables, any payments received from a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a reversal of the provision is recorded to the extent of the residual cash received. Once the collectability issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of Finance Income. When a customer’s aging exceeds 90 days, the Company’s policy is to perform an enhanced review to assess collectability of the theater’s past due accounts. The over 90 days past due category may be an indicator of potential impairment as up to 90 days outstanding is considered to be a reasonable time to resolve any issues. The Company develops an estimate of expected credit losses by class of receivable and customer type through a calculation that utilizes historical loss rates, which are then adjusted for specific receivables that are judged to have a higher-than-normal risk profile after considering management’s internal credit quality classifications. Additional credit loss provisions are also recorded taking into account macro-economic and industry risk factors. The write-off of any billed receivable balance requires the approval of management. Management’s judgments regarding expected credit losses are based on the facts available to management and involve estimates about the future. As a result, the Company’s judgments and associated estimates of credit losses may ultimately prove, with the benefit of hindsight, to be incorrect. The impacts of inflation, and rising interest rates may impact future credit losses. The Company will continue to monitor economic trends and conditions and portfolio performance and adjust its allowance for credit loss accordingly. Accounts Receivable Accounts receivable principally includes amounts currently due to the Company under IMAX System sale and sales-type lease arrangements, contingent fees owed by theater operators as a result of box office performance, and fees for maintenance services. Accounts receivable also includes amounts due to the Company from movie studios and other content creators principally for digitally remastering films into IMAX formats, as well as for film distribution and post-production services. The following tables summarize the activity in the allowance for credit losses related to Accounts Receivable for the three months ended March 31, 2024 and 2023: Three Months Ended March 31,2024 (In thousands of U.S. Dollars) Theater Studios Other Total Beginning balance $ 14,355 $ 616 $ 1,006 $ 15,977 Current period (reversal) provision, net ( 94 ) 14 73 ( 7 ) Foreign exchange ( 14 ) — — ( 14 ) Ending balance $ 14,247 $ 630 $ 1,079 $ 15,956 Three Months Ended March 31, 2023 (In thousands of U.S. Dollars) Theater Studios Other Total Beginning balance $ 11,144 $ 1,699 $ 1,276 $ 14,119 Current period provision, net ( 265 ) 3 21 ( 241 ) Write-offs ( 115 ) — — ( 115 ) Foreign exchange 60 5 — 65 Ending balance $ 10,824 $ 1,707 $ 1,297 $ 13,828 For the three months ended March 31, 2024 , the Company’s allowance for current expected credit losses related to Accounts Receivable decreased less than $ 0.1 million. There were no write-offs in the allowance for credit losses for the three months ended March 31, 2024. For the three months ended March 31, 2023 , the Company’s allowance for current expected credit losses related to Accounts Receivable decreased by $ 0.4 million. Financing Receivables Financing receivables are due from theater operators and consist of the Company’s net investment in sales-type leases and receivables associated with financed sales of IMAX Systems. As of March 31, 2024 and December 31, 2023, financing receivables consist of the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Net investment in leases Gross minimum payments due under sales-type leases $ 30,215 $ 30,459 Unearned finance income ( 441 ) ( 467 ) Present value of minimum payments due under sales-type leases 29,774 29,992 Allowance for credit losses ( 451 ) ( 453 ) Net investment in leases 29,323 29,539 Financed sales receivables Gross minimum payments due under financed sales 133,511 135,684 Unearned finance income ( 27,604 ) ( 28,452 ) Present value of minimum payments due under financed sales 105,907 107,232 Allowance for credit losses ( 9,616 ) ( 9,617 ) Net financed sales receivables 96,291 97,615 Total financing receivables $ 125,614 $ 127,154 Net financed sales receivables due within one year $ 31,700 $ 32,031 Net financed sales receivables due after one year 64,591 65,584 Total financed sales receivables $ 96,291 $ 97,615 As of March 31, 2024 and December 31, 2023, the weighted-average remaining lease term and weighted-average interest rate associated with the Company’s sales-type lease arrangements and financed sale receivables, as applicable, are as follows: March 31, December 31, 2024 2023 Weighted-average remaining lease term (in years) Sales-type lease arrangements 8.1 8.3 Weighted-average interest rate Sales-type lease arrangements 7.56 % 7.88 % Financed sales receivables 9.01 % 8.97 % The tables below provide information on the Company’s net investment in leases by credit quality indicator as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. (In thousands of U.S. Dollars) By Origination Year As of March 31, 2024 2024 2023 2022 2021 2020 Prior Total Net investment in leases: Credit quality classification: In good standing $ — $ 2,278 $ 3,072 $ 5,664 $ 1,771 $ 7,388 $ 20,173 Credit Watch — — — — — — — Pre-approved transactions — — 490 2,602 809 5,299 9,200 Transactions suspended — — — — — 401 401 Total net investment in leases $ — $ 2,278 $ 3,562 $ 8,266 $ 2,580 $ 13,088 $ 29,774 (In thousands of U.S. Dollars) By Origination Year As of December 31, 2023 2023 2022 2021 2020 2019 Prior Total Net investment in leases: Credit quality classification: In good standing $ 2,435 $ 3,262 $ 6,241 $ 2,173 $ 1,677 $ 1,138 $ 16,926 Credit Watch — 490 — — — 313 803 Pre-approved transactions — 3,462 1,182 5,221 1,997 11,862 Transactions suspended — — — — — 401 401 Total net investment in leases $ 2,435 $ 3,752 $ 9,703 $ 3,355 $ 6,898 $ 3,849 $ 29,992 The tables below provide information on the Company’s financed sales receivables by credit quality indicator as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. (In thousands of U.S. Dollars) By Origination Year As of March 31, 2024 2024 2023 2022 2021 2020 Prior Total Financed sales receivables: Credit quality classification: In good standing $ 349 $ 10,849 $ 5,784 $ 6,001 $ 5,333 $ 49,560 $ 77,876 Credit Watch — — — — — 1,089 1,089 Pre-approved transactions — 471 342 2,904 1,513 8,968 14,198 Transactions suspended — 163 — 630 146 11,805 12,744 Total financed sales receivables $ 349 $ 11,483 $ 6,126 $ 9,535 $ 6,992 $ 71,422 $ 105,907 (In thousands of U.S. Dollars) By Origination Year As of December 31, 2023 2023 2022 2021 2020 2019 Prior Total Financed sales receivables: Credit quality classification: In good standing $ 6,660 5,921 5,961 5,415 8,058 44,870 $ 76,885 Credit Watch — 30 — — 317 796 1,143 Pre-approved transactions 607 313 2,619 1,455 2,084 8,508 15,586 Transactions suspended — 728 345 1,546 10,999 13,618 Total financed sales receivables $ 7,267 $ 6,264 $ 9,308 $ 7,215 $ 12,005 $ 65,173 $ 107,232 The following tables provide an aging analysis for the Company’s net investment in leases and financed sales receivables as of March 31, 2024 and December 31, 2023: As of March 31, 2024 (In thousands of U.S. Dollars) Accrued 30-89 90+ Billed Unbilled Recorded Allowance Net Net investment in leases $ 277 $ 451 $ 4,973 $ 5,701 $ 24,073 $ 29,774 $ ( 451 ) $ 29,323 Financed sales receivables 853 2,241 9,994 13,089 92,818 $ 105,907 ( 9,616 ) 96,291 Total $ 1,130 $ 2,692 $ 14,967 $ 18,790 $ 116,891 $ 135,681 $ ( 10,067 ) $ 125,614 As of December 31, 2023 (In thousands of U.S. Dollars) Accrued 30-89 90+ Billed Unbilled Recorded Allowance Net Net investment in leases $ 293 $ 212 $ 4,598 $ 5,103 $ 24,889 $ 29,992 $ ( 453 ) $ 29,539 Financed sales receivables 1,535 1,196 10,704 13,435 93,797 107,232 ( 9,617 ) 97,615 Total $ 1,828 $ 1,408 $ 15,302 $ 18,538 $ 118,686 $ 137,224 $ ( 10,070 ) $ 127,154 The following tables provide information about the Company’s net investment in leases and financed sales receivables with billed amounts past due for which it continues to accrue finance income as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. As of March 31, 2024 (In thousands of U.S. Dollars) Accrued 30-89 Days 90+ Days Billed Unbilled Allowance Net Net investment in leases $ 240 $ 412 $ 4,973 $ 5,625 $ 22,036 $ ( 10 ) $ 27,651 Financed sales receivables 373 1,555 9,662 11,590 36,236 ( 1,046 ) 46,780 Total $ 613 $ 1,967 $ 14,635 $ 17,215 $ 58,272 $ ( 1,056 ) $ 74,431 As of December 31, 2023 (In thousands of U.S. Dollars) Accrued 30-89 Days 90+ Days Billed Unbilled Allowance Net Net investment in leases $ 259 $ 212 $ 4,598 $ 5,069 $ 22,651 $ ( 9 ) $ 27,711 Financed sales receivables 798 782 10,517 12,097 33,552 ( 1,198 ) 44,451 Total $ 1,057 $ 994 $ 15,115 $ 17,166 $ 56,203 $ ( 1,207 ) $ 72,162 The following table provides information about the Company’s net investment in leases and financed sales receivables that are on nonaccrual status as of March 31, 2024 and December 31, 2023: As of March 31, 2024 As of December 31, 2023 (In thousands of U.S. Dollars) Recorded Allowance Net Recorded Allowance Net Net investment in leases $ 401 $ ( 401 ) $ — $ 401 $ ( 401 ) $ — Net financed sales receivables 26,942 ( 8,882 ) 18,060 29,204 ( 8,884 ) 20,320 Total $ 27,343 $ ( 9,283 ) $ 18,060 $ 29,605 $ ( 9,285 ) $ 20,320 For the three months ended March 31, 2024 , the Company recognized $ 0.6 million (2023 — less than $ 0.1 million) in Finance Income related to the net investment in leases with billed amounts past due. For the three months ended March 31, 2024 and 2023, the Company recognized $nil (2023 - $nil) in Finance Income related to the net investment in leases on nonaccrual status. For the three months ended March 31, 2024 , the Company recognized $ 0.5 million (2023 — $ 0.8 million) in Finance Income related to the financed sales receivables with billed amounts past due. For the three months ended March 31, 2024 , the Company recognized $ 0.4 million (2023 — $ 0.1 million ) in Finance Income related to the financed sales receivables in nonaccrual status. The f ollowing tables summarize the activity in the allowance for credit losses related to the Company’s net investment in leases and financed sales receivables for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 Net Investment Financed (In thousands of U.S. Dollars) in Leases Sales Receivables Beginning balance $ 453 $ 9,617 Current period (reversal) provision, net 4 ( 4 ) Foreign exchange ( 6 ) 3 Ending balance $ 451 $ 9,616 Three Months Ended March 31, 2023 Net Investment Net Financed (In thousands of U.S. Dollars) in Leases Sales Receivables Beginning balance $ 776 $ 10,945 Current period (reversal) provision, net ( 2 ) 549 Foreign exchange 4 39 Ending balance $ 778 $ 11,533 For the three months ended March 31, 2024, the Company’s allowance for current expected credit losses related to its net investment in leases decreased by less t han $ 0.1 million (2023 — increased less than $ 0.1 million ), a nd financed sales receivables decreased by less than $ 0.1 million (2023 — increased by $ 0.6 million). Variable Consideration Receivables In sale arrangements, variable consideration may become due to the Company from theater operators if certain annual minimum box office receipt thresholds are exceeded. Such variable consideration is recorded as revenue in the period when the sale is recognized and adjusted in future periods based on actual results and changes in estimates. Variable consideration is only recognized to the extent the Company believes there is not a risk of significant revenue reversal. The following table summarizes the activity in the Allowance for Credit Losses related to Variable Consideration Receivables for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 (In thousands of U.S. Dollars) Theater Theater Beginning balance $ 633 $ 610 Current period reversal, net 3 ( 86 ) Foreign exchange — 2 Ending balance $ 636 $ 526 For the three months ended March 31, 2024, the Company’s allowance for current expected credit losses related to Variable Consideration Receivables increased by less than $ 0.1 million (2023 — dec reased by $ 0.1 million)

Lease Arrangements

Lease Arrangements	3 Months Ended
Lease Arrangements	Mar. 31, 2024
Leases [Abstract]
Lease Arrangements	4. Lease Arrangements (a) IMAX Corporation as a Lessee The Company’s operating lease arrangements principally involve office and warehouse space. Office equipment is generally purchased outright. Leases with an initial term of less than 12 months are not recorded on the Condensed Consolidated Balance Sheets and the related lease expense is recognized on a straight-line basis over the lease term. Most of the Company’s leases include one or more options to renew, with renewal terms that can extend the lease term from one to five years or more. The Company has determined that it is reasonably certain that the renewal options on its warehouse leases will be exercised based on previous history, its current understanding of future business needs and its level of investment in leasehold improvements, among other factors. The incremental borrowing rate used in the calculation of the Company’s lease liabilities is based on the location of each leased property. None of the Company’s leases include options to purchase the leased property. The depreciable lives of right-of-use assets and related leasehold improvements are limited by the expected lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. In 2022, the Company entered into a finance lease arrangement involving equipment used to facilitate the delivery of live events to certain IMAX locations. The lease arrangement includes an option for the Company to purchase the equipment at the end of the lease term that is reasonably certain to be exercised. The resulting right-of-use assets are being depreciated from the lease commencement dates over the useful life of the underlying equipment. The incremental borrowing rate used in the calculation of the lease liabilities is based on the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term. For the three months ended March 31, 2024 and 2023, the components of lease expense recorded within Selling, General and Administrative Expenses are as follows: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Operating lease cost: Amortization of operating lease assets $ 522 $ 151 Interest on operating lease liabilities 175 724 Short-term and variable lease costs 78 204 Finance lease cost: Amortization of finance lease assets 100 100 Interest on finance lease liabilities 7 14 Total lease cost $ 882 $ 1,193 For the three months ended March 31, 2024 and 2023, supplemental cash and non-cash information related to leases is as follows: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating leases $ 723 $ 971 Finance leases $ 28 $ — Supplemental disclosure of noncash leasing activities: Right-of-use assets obtained in exchange for operating lease obligations $ 260 $ 228 Right-of-use assets obtained in exchange for finance lease obligations $ — $ — As of March 31, 2024 and December 31, 2023, supplemental balance sheet information related to leases is as follows: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Assets Balance Sheet Location Operating lease right-of-use assets Property, plant and equipment $ 10,263 $ 10,599 Finance lease right-of-use assets Property, plant and equipment $ 1,320 $ 1,420 Liabilities Balance Sheet Location Operating lease liabilities Accrued and other liabilities $ 12,353 $ 12,702 Finance lease liabilities Accrued and other liabilities $ 497 $ 518 As of March 31, 2024 and December 31, 2023, the weighted-average remaining lease term and weighted-average interest rate associated with the Company’s leases are as follows: March 31, December 31, 2024 2023 Operating leases: Weighted-average remaining lease term (years) 5.4 4.9 Weighted-average discount rate 5.83 % 5.85 % Finance leases: Weighted-average remaining lease term (years) 3.3 3.6 Weighted-average discount rate 6.00 % 6.00 % As of March 31, 2024, the maturities of the Company’s operating and finance lease liabilities are as follows: (In thousands of U.S. Dollars) Operating Leases Finance Leases 2024 (nine months remaining) $ 1,998 $ 508 2025 2,528 — 2026 2,469 — 2027 2,468 — 2028 2,472 — Thereafter 2,429 — Total lease payments 14,364 508 Less: interest expense ( 2,011 ) ( 11 ) Present value of lease liabilities $ 12,353 $ 497 (b) IMAX Corporation as a Lessor The Company provides IMAX Systems to customers through long-term lease arrangements that for accounting purposes are classified as sales-type leases. Under these arrangements, in exchange for providing the IMAX System, the Company earns fixed upfront and ongoing consideration. Certain arrangements that are legal sales are also classified as sales-type leases as certain clauses within the arrangements limit transfer of title or provide the Company with conditional rights to the system. The customer’s rights under the Company’s sales-type lease arrangements are described in Note 2(o) of the Company’s audited Consolidated Financial Statements included in its 2023 Form 10-K. Under the Company’s sales-type lease arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s lease portfolio terms are typically non-cancellable for 10 to 20 year s w ith renewal provisions from inception. The Company’s sales-type lease arrangements do not contain a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and an extended warranty generally after the first year of the lease until the end of the lease term. The customer is responsible for obtaining insurance coverage for the IMAX System commencing on the date specified in the arrangement’s shipping terms and ending on the date the IMAX System is returned to the Company. The Company also provides IMAX Systems to customers through joint revenue sharing arrangements. Under the traditional form of these arrangements, in exchange for providing the IMAX System under a long-term lease, the Company earns rent based on a percentage of contingent box office receipts and, in some cases, concession revenues, rather than a fixed upfront fee or annual minimum payments. Under certain other joint revenue sharing arrangements, known as hybrid arrangements, the customer is responsible for making fixed upfront payments prior to the delivery and installation of the IMAX System. Under joint revenue sharing arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s joint revenue sharing arrangements are typically non-cancellable for 10 years or longer with renewal provisions. Title to the IMAX System under a joint revenue sharing arrangement generally does not transfer to the customer. The Company’s joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and an extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the IMAX System commencing on the date specified in the arrangement’s shipping terms and ending on the date the IMAX System is returned to the Company. The following lease payments are expected to be received by the Company for its sales-type leases and joint revenue sharing arrangements in each of the next five years and thereafter following the March 31, 2024 balance sheet date: Sales-Type Joint Revenue (In thousands of U.S. Dollars) Leases Sharing Arrangements 2024 (nine months remaining) $ 2,433 $ 48 2025 3,112 27 2026 3,031 — 2027 2,965 — 2028 2,813 — Thereafter 15,664 — Total $ 30,018 $ 75

Inventories

Inventories	3 Months Ended
Inventories	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories	5. Inventories As of March 31, 2024 and December 31, 2023, Inventories consist of the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Raw materials $ 31,980 $ 27,660 Work-in-process 2,089 2,570 Finished goods 2,084 1,354 $ 36,153 $ 31,584 As of March 31, 2024, Inventories include finished goods of $ 0.6 million (December 31, 2023 — $ 0.6 million ) for which title had passed to customers, but the criteria for revenue recognition were not met as of the balance sheet date. During the three months ended March 31, 2024 and 2023, the Company had recorded write-downs of less than $ 0.1 million, respectively, in Costs and Expenses Applicable to Revenues ― Technology Sales .

Borrowings

Borrowings	3 Months Ended
Borrowings	Mar. 31, 2024
Debt Disclosure [Abstract]
Borrowings	6. Borrowings (a) Revolving Credit Facility Borrowings, Net As of March 31, 2024 and December 31, 2023, Revolving Credit Facility Borrowings, Net includes the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Wells Fargo Credit Facility borrowings $ 69,000 $ 24,000 Unamortized debt issuance costs ( 966 ) ( 1,076 ) Revolving Credit Facility Borrowings, net $ 68,034 $ 22,924 Wells Fargo Credit Agreement On March 25, 2022, the Company entered into a Sixth Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as agent (the “Agent”), and a syndicate of lenders party thereto (the “Credit Agreement”), which extended the maturity date of the credit facility under the Credit Agreement (the “Credit Facility”) from June 28, 2023 to March 25, 2027 . The Company’s obligations under the Credit Agreement are guaranteed by certain of the Company’s subsidiaries (the “Guarantors”), and are secured by first-priority security interests in substantially all of the assets of the Company and the Guarantors. The Credit Agreement has a revolving borrowing capacity of $ 300.0 million, and contains an uncommitted accordion feature allowing the Company to further increase its borrowing capacity by the greater of $ 140.0 million, for a total of $ 440.0 million, or by the Company’s EBITDA for the sum of the four most recently ended fiscal quarters, subject to certain conditions, depending on the mix of revolving loans and/or term loans under the incremental facility and subject to conditions set forth in the Credit Agreement. The Credit Facility requires that the Company maintain a maximum Senior Secured Net Leverage Ratio (as defined in the Credit Agreement) of no greater than 3.25 :1.00, on the last day of each Fiscal Quarter. The Senior Secured Net Leverage Ratio is the ratio of Total Debt (as defined in the Credit Agreement), secured by liens, net of unrestricted cash and cash equivalents held outside of the People’s Republic of China (“the PRC”) up to a maximum of $ 75.0 million, relative to Adjusted EBITDA per Credit Facility for the four prior quarters. The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis. The Company was in compliance with this requirement as of March 31, 2024 as the Senior Secured Net Leverage Ratio was 0.16 :1.00. Loans under the Credit Facility bear interest, at the Company’s option, at (i) Term Secure Overnight Financing Rate (“SOFR”), Eurocurrency Rate or Canadian Dollar Offered Rate (“CDOR”) plus a margin ranging from 1.00 % to 1.75 % per annum; or (ii) the U.S. base rate or the Canadian prime rate plus a margin ranging from 0.25 % to 1.00 % per annum, in each case depending on the Company’s total leverage ratio. In no event will Term SOFR, Eurocurrency Rate or CDOR Rate be less than 0.00 % per annum. As of March 31, 2024, borrowings under the Credit Facility were $ 69.0 million (December 31, 2023 — $ 24.0 million ) and bear interest at Term SOFR, plus a margin of 1.50 % per annum (December 31, 2023 — 1.75 %) based on the Company’s total leverage ratio. The effective interest rate for the three months ended March 31, 2024 was 6.93 % (2023 — 6.83 % ). The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit indebtedness, liens, asset sales, investments and restricted payments, in each case subject to negotiated exceptions and baskets. The Credit Agreement also contains customary representations, warranties and event of default provisions. As of March 31, 2024, and December 31, 2023 , the Company had no letters of credit or advance payment guarantees outstanding under the Credit Facility. As of March 31, 2024, the amount available for future borrowings under the Credit Facility was $ 231.0 million (December 31, 2023 — $ 276.0 million ). Foreign Exchange Facility Within the Credit Facility, the Company is able to purchase foreign currency forward contracts and/or other swap arrangements. As of March 31, 2024, the net unrealized loss on the Company’s outstanding foreign currency forward contracts was less than $ 0.1 million , representing the amount by which the notional value of these forward contracts exceeded their fair value (December 31, 2023 — net unrealized gain of $ 0.8 million). As of March 31, 2024, the notional value of the Company’s outstanding foreign currency forward contracts was $ 34.8 million (December 31, 2023 — $ 40.6 million). Bank of China Facility In June 2022, IMAX (Shanghai) Multimedia Technology Co., Ltd. (“IMAX Shanghai”), one of the Company’s majority-owned subsidiaries in China, renewed its unsecured revolving facility with Bank of China for up to 200.0 million Chinese Renminbi (“RMB”) ($ 28.2 million ), including RMB 10.0 million ($ 1.4 million) for letters of guarantee, to fund ongoing working capital requirements (the “Bank of China Facility”). The Bank of China Facility expires on February 21, 2025 . As of March 31, 2024 and December 31, 2023, no borrowings were outstanding under the Bank of China Facility and outstanding letters of guarantee were less than $ 0.1 millio n. As of March 31, 2024, the amount available for future borrowings under the Bank of China Facility was RM B 190.0 million ( $ 26.8 million ) and the amount available for letters of guarantee was RMB 9.8 million ( $ 1.4 million ). The amount available for future borrowings under the Bank of China Facility is not subject to a standby fee. The effective interest rate for the three months ended March 31, 2024 was 0 % (2023 — 3.85 % ). HSBC China Facility In June 2022, IMAX Shanghai entered into an unsecured revolving facility for up to RMB 200.0 million ( $ 28.2 million ) with HSBC Bank (China) Company Limited, Shanghai Branch to fund ongoing working capital requirements (the “HSBC China Facility”). As of March 31, 2024 and December 31, 2023 , no borrowings were outstanding under the HSBC China Facility. As of March 31, 2024 and December 31, 2023 , the amount available for future borrowings under the HSBC China Facility was RMB 200.0 million ( $ 28.2 million ). The effective interest rate for the three months ended March 31, 2024 was 0 % (2023 — 3.88 % ). NBC Facility In October 2019, the Company entered into a $ 5.0 million facility with National Bank of Canada (the “NBC Facility”) fully insured by Export Development Canada for use solely in conjunction with the issuance of performance guarantees and letters of credit. The NBC Facility has been renewed to August 21, 2024. The NBC Facility is renewable on the same terms and conditions on an annual basis. The Company did no t have any letters of credit or advance payment guarantees outstanding as of March 31, 2024 and December 31, 2023 under the NBC Facility. (b) Convertible Notes and Other Borrowings, Net As of March 31, 2024 and December 31, 2023, Convertible Notes and Other Borrowings, Net includes the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Convertible Notes $ 230,000 $ 230,000 Unamortized discounts and debt issuance costs ( 2,991 ) ( 3,367 ) Convertible Notes, net 227,009 226,633 Federal Economic Development Loan 2,962 3,200 Unaccreted interest benefit ( 536 ) ( 702 ) Federal Economic Development Loan, net 2,426 2,498 Convertible Notes and Other Borrowings, net $ 229,435 $ 229,131 Convertible Notes On March 19, 2021, the Company issued $ 230.0 million of 0.500 % Convertible Senior Notes due 2026 (the “Convertible Notes”) in a private placement conducted pursuant to Rule 144A under the Securities Act of 1933, as amended. The net proceeds from the issuance of the Convertible Notes were $ 223.7 million, after deducting the initial purchasers ’ discounts and commissions. The Convertible Notes are senior unsecured obligations of the Company and bear interest at a rate of 0.500 % per annum on the principal of $ 230.0 million, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on October 1, 2021 . The Convertible Notes will mature on April 1, 2026 , unless they are redeemed or repurchased by the Company or converted on an earlier date. Holders of the Convertible Notes have the right to convert their Convertible Notes in certain circumstances and during specified periods. Before January 1, 2026, holders of the Convertible Notes have the right to convert their Convertible Notes only upon the occurrence of certain events. From and after January 1, 2026, holders of the Convertible Notes may convert their Convertible Notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. Upon conversion, the Company will pay or deliver, as applicable, cash or a combination of cash (in an amount no less than the principal amount of the Convertible Notes being converted) and common shares, at its election, based on the applicable conversion rates. The initial conversion rate is 34.7766 common shares per $ 1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $ 28.75 per common share, and is subject to adjustment upon the occurrence of certain events. The Convertible Notes are redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after April 6, 2024 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, but only if the last reported sale price per share of the Company’s common stock exceeds 130 % of the conversion price for a specified period of time. In addition, calling any Convertible Notes for redemption will constitute a “make-whole fundamental change” with respect to such notes, in which case the conversion rate applicable to the conversion of such notes will be increased in certain circumstances if such notes are converted after they are called for redemption. In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”) with certain financial institutions. The Capped Call Transactions are expected to reduce potential dilution resulting from the common shares the Company is required to issue and/or to offset any potential cash payments the Company is required to make in excess of the principal amount of the Convertible Notes in the event that the market price per share of the Company’s common shares is greater than the strike price of the Capped Call Transactions with such reduction and/or offset subject to a cap. The Capped Call Transactions have an initial cap price of $ 37.2750 per share of the Company’s common shares, which represents a premium of 75 % over the last reported sale price of the common shares when they were priced on March 16, 2021, and are subject to certain adjustments under the terms of the Capped Call Transactions. Collectively, the Capped Call Transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to the Convertible Notes, the number of the Company’s common shares underlying the Convertible Notes. The cost of the Capped Call Transactions was approximately $ 19.1 million. The Capped Call Transactions are separate transactions, are not part of the terms of the Convertible Notes and will not affect any holder’s rights under the Convertible Notes. Holders of the Convertible Notes will not have any rights with respect to the Capped Call Transactions. The Capped Call Transactions meet all of the applicable criteria for equity classification in accordance with ASC 815-10-15-74(a), “Derivatives and Hedging—Embedded Derivatives—Certain Contracts Involving an Entity’s Own Equity,” and, as a result, the related $ 19.1 million cost was recorded as a reduction to Other Equity within Shareholders’ Equity on the Company’s Condensed Consolidated Statements of Shareholders’ Equity and Condensed Consolidated Balance Sheets. In addition, upon the occurrence of a “fundamental change” (as defined below), holders may require the Company to repurchase their Convertible Notes at a cash repurchase price equal to the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest, if any. Subject to the terms and conditions of the indenture governing the Convertible Notes, a “fundamental change” means, among other things, an event resulting in (i) a change of control, (ii) a transfer of all or substantially all of the assets of the Company, (iii) a merger, (iv) liquidation or dissolution of the Company, or (v) delisting of the Company’s common shares from a national securities exchange. The Company continues to record the Convertible Notes entirely as a liability in the Condensed Consolidated Balance Sheets, net of initial purchasers’ discounts and commissions and other debt issuance costs, with interest expense reflecting the cash coupon plus the amortization of the discounts and capitalized costs. Additionally, under the “if-converted” method, because the principal amount of the Convertible Notes is settled in cash and the conversion spread is settleable in the Company’s common shares, diluted earnings per share is calculated by including the net number of incremental shares that would be issued upon conversion of the Convertible Notes, using the average market price during the period. Accordingly, the application of the “if-converted” method may reduce the Company’s reported diluted earnings per share. Federal Economic Development Loan The Company’s wholly-owned subsidiary, SSIMWAVE, entered into a contribution agreement with the Federal Economic Development Agency for Southern Ontario (the “Federal Economic Development Loan” ) on May 29, 2019, under which SSIMWAVE received $ 4.2 million Canadian Dollars ( $ 3.1 million) by way of repayable contributions toward certain eligible projects costs. The contributions under the agreement covered 35 % of the eligible and supported costs of SSIMWAVE between January 10, 2019 and December 31, 2022. The contributions were repayable over 60 months , with repayments to begin in January 2024 and an annual interest rate of 0 %. On January 1, 2024, SSIMWAVE was amalgamated into the Company. On January 4, 2024, the Federal Economic Development Loan was assigned to the Company with amendment to the repayment term. The contributions under the assigned agreement are repayable over 36 months beginning January 2024 , with an annual interest rate of 0 %. The benefit of the interest-free loan has been determined by calculating the present value of the payments using a market-based interest rate and comparing this to the proceeds received. The benefit is recorded as the interest free benefit of government funding within Interest Income on the Condensed Consolidated Statements of Operations. The obligation is being accreted to its maturity amount, resulting in an interest accretion expense of $ 0.1 million for the three months ended March 31, 2024 (2023 — less than $ 0.1 million), which is being recorded within Interest Expense on the Company’s Consolidated Statement of Operations. As of March 31, 2024, the Federal Economic Development Loan has a carrying value of $ 2.4 million , net of unaccreted interest benefit and is recorded within Convertible Notes and Other Borrowings, Net on the Company’s Condensed Consolidated Balance Sheets.

Commitments, Contingencies and

Commitments, Contingencies and Guarantees	3 Months Ended
Commitments, Contingencies and Guarantees	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments, Contingencies and Guarantees	7. Commitments, Contingencies and Guarantees (a) Commitments In the ordinary course of its business, the Company enters into contractual agreements with third parties that include non-cancelable payment obligations, for which it is liable in future periods. These arrangements can include terms binding the Company to minimum payments and/or penalties if it terminates the agreement for any reason other than an event of default as described by the agreement. (b) Contingencies and guarantees The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. Management is required to assess the likelihood of any adverse judgments or outcomes related to these legal contingencies, as well as potential ranges of probable or reasonably possible losses. The Company records a provision for a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The determination of the amount of any liability recorded or disclosed is reviewed at least quarterly based on a careful analysis of each individual exposure with, in some cases, the assistance of outside legal counsel, taking into account the impact of negotiations, settlements, rulings, and other pertinent information related to the case. The amount of liabilities recorded or disclosed for these contingencies may change in the future due to changes in management’s judgments resulting from new developments or changes in settlement strategy. Any resulting adjustment to the liabilities recorded by the Company could have a material adverse effect on its results of operations, cash flows, and financial position in the period or periods in which such changes in judgment occur. The Company believes it has adequate provisions for any such matters. The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred. (i) In January 2004, the Company and IMAX Theatre Services Ltd., a subsidiary of the Company, commenced an arbitration seeking damages before the International Court of Arbitration of the International Chamber of Commerce (the “ICC”) with respect to the breach by Electronic Media Limited (“EML”) of its December 2000 agreement with the Company. In June 2004, the Company commenced a related arbitration before the ICC against EML’s affiliate, E-City Entertainment (I) PVT Limited (“E-City”). On March 27, 2008, the arbitration panel issued a final award in favor of the Company in the amount of $ 11.3 millio n, as well as an additional $ 2,512 each day in interest from October 1, 2007 until the date the award is paid . In July 2008, E-City commenced a proceeding in Mumbai, India seeking to prevent recognition of the ICC award in India. On March 10, 2017, the Supreme Court of India dismissed E-City’s petition. On March 29, 2017, the Company filed an Execution Application in the Bombay High Court seeking to enforce the ICC award against E-City and several related parties, which award the Company calculates to be $ 26.4 million , inclusive of interest, as of March 31, 2024 . That matter is currently pending. The Company has also taken steps to enforce the ICC final award outside of India. In December 2011, the Ontario Superior Court of Justice issued an order recognizing the final award and requiring E-City to pay the Company $ 30,000 to cover the costs of the application , and in May 2012, the New York Supreme Court recognized the Canadian judgment and entered it as a New York judgment. The Company intends to continue pursuing its rights and seeking to enforce the award, although no assurances can be given with respect to the ultimate outcome. (ii) In addition to the matters described above, the Company is currently involved in other legal proceedings or governmental inquiries which, in the opinion of the Company’s management, will not materially affect the Company’s financial position or future operating results, although no assurance can be given with respect to the ultimate outcome of any such proceedings. (iii) In the normal course of business, the Company enters into agreements that may contain features that meet the definition of a guarantee. A guarantee is a contract (including an indemnity) that contingently requires the Company to make payments (either in cash, financial instruments, other assets, shares of its stock, or provision of services) to a third party based on (a) changes in an underlying interest rate, foreign exchange rate, equity or commodity instrument, index or other variable, that is related to an asset, a liability or an equity security of the counterparty, (b) failure of another party to perform under an obligating agreement or (c) failure of another third party to pay its indebtedness when due. (c) Financial Guarantees Certain subsidiaries of the Company have provided significant financial guarantees to third parties under the Credit Agreement. (d) Product Warranties The Company’s accrual for product warranties, which is recorded within Accrued and Other Liabilities in the Condensed Consolidated Balance Sheets, was $ 0.2 m illion and less than $ 0.1 million as of March 31, 2024 and December 31, 2023, respectively. (e) Director and Officer Indemnifications The Company’s by-laws contain an indemnification of its directors/officers, former directors/officers, and persons who have acted at its request to be a director/officer of an entity in which the Company is a shareholder or creditor, to indemnify them, to the extent permitted by the Canada Business Corporations Act , against expenses (including legal fees), judgments, fines and any amounts actually and reasonably incurred by them in connection with any action, suit or proceeding in which the directors and/or officers are sued as a result of their service, if they acted honestly and in good faith with a view to the best interests of the Company. In addition, the Company has entered into indemnification agreements with each of its directors in order to effectuate the foregoing. The nature of the indemnification prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. The Company has purchased directors’ and officers’ liability insurance. No amount has been accrued in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023, with respect to this indemnity. (f) Other Indemnification Agreements In the normal course of its operations, the Company provides indemnifications to counterparties in transactions such as: IMAX System lease and sale agreements and the supervision of installation or servicing of IMAX Systems; film production, exhibition and distribution agreements; real property lease agreements; and employment agreements. These indemnification agreements require the Company to compensate the counterparties for costs incurred as a result of litigation claims that may be suffered by the counterparty as a consequence of the transaction or the Company’s breach or non-performance under these agreements. While the terms of these indemnification agreements vary based upon the contract, they normally extend for the life of the agreements. A small number of agreements do not provide for any limit on the maximum potential amount of indemnification; however, virtually all of the IMAX System lease and sale agreements limit such maximum potential liability to the purchase price of the system. The fact that the maximum potential amount of indemnification required by the Company is not specified in some cases prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. Historically, the Company has no t made any significant payments under such indemnifications and no amounts have been accrued in the Condensed Consolidated Financial Statements with respect to the contingent aspect of these indemnities.

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Operations Supplemental Information	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Condensed Consolidated Statements of Operations Supplemental Information	8. Condensed Consolidated Statements of Operations – Supplemental Information (a) Selling Expenses The following table summarizes the Company’s selling expenses, including sales commissions and marketing and other, which are recognized within Costs and Expenses Applicable to Revenues in the Condensed Consolidated Statements of Operations, for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 (In thousands of U.S. Dollars) Sales Marketing Sales Marketing Technology sales (1) $ 78 $ 166 $ 200 $ 16 Image enhancement and maintenance services (2) — 2,575 — 6,772 Technology rentals (3) 109 440 73 260 Total $ 187 $ 3,181 $ 273 $ 7,048 (1) Sales commissions paid prior to the recognition of the related revenue are deferred and recognized upon the client acceptance of the IMAX System. Direct advertising and marketing costs for each IMAX System are expensed as incurred. (2) Film exploitation costs, including advertising and marketing costs, are expensed as incurred. (3) Sales commissions related to joint revenue sharing arrangements accounted for operating leases are recognized in the month earned by the salesperson, which is typically the month in which the IMAX System is installed, and are subject to subsequent performance-based adjustments. Direct advertising and marketing costs for each IMAX System are expensed as incurred. (b) Foreign Exchange Included in Selling, General and Administrative Expenses for the three months ended March 31, 2024 is a foreign currency net loss of $ 0.3 million (2023 — net loss of $ 0.1 million ) resulting from changes in exchange rates related to foreign currency denominated monetary assets and liabilities. See Note 15(c) for additional information. (c) Collaborative Arrangements Joint Revenue Sharing Arrangements The accounting policy for the Company’s joint revenue sharing arrangements is disclosed in Note 2(o) of the Company’s audited Consolidated Financial Statements in its 2023 Form 10-K. Revenue attributable to transactions arising between the Company and its customers under joint revenue sharing arrangements are recorded within Revenues — Technology Sales (for hybrid joint revenue sharing arrangements) and Revenues — Technology Rentals (for traditional joint revenue sharing arrangements). For the three months ended March 31, 2024 , such revenues totaled $ 19.3 million (2023 —$ 20.1 million). IMAX Film Remastering and Distribution In an IMAX Film Remastering and distribution arrangement, the Company receives a percentage of the box office receipts from a third party who owns the copyright to a film in exchange for converting the film into IMAX format and distributing it through the IMAX network . The fee earned by the Company in a typical IMAX Film Remastering and distribution arrangement averages approximately 12.5 % of box office receipts (i.e. gross box office receipts less applicable sales taxes), except for within mainland China, where the Company receives a lower percentage of net box office receipts for certain Hollywood films. The accounting policy for the Company’s IMAX Film Remastering and distribution arrangements is disclosed in Note 2(o) of the Company’s audited Consolidated Financial Statements in its 2023 Form 10-K. Revenue attributable to transactions arising between the Company and its customers under IMAX Film Remastering and distribution arrangements are included in Revenues – Image Enhancement and Maintenance Services. For the three months ended March 31, 2024, such revenues totaled $ 29.7 million (2023 — $ 30.1 million ). See Note 12(a) for a disaggregated presentation of the Company’s revenues. Co-Produced Film Arrangements In certain film arrangements, the Company co-produces a film with a third party whereby the third party retains the copyright and certain other rights to the film. In some cases, the Company obtains exclusive theatrical distribution rights to the film. Under these arrangements, both parties contribute to the funding of the production, distribution and exploitation costs associated with the film. As of March 31, 2024 , the Company is party to one co-produced film arrangement, which represents the VIE total assets balance of $ 1.4 million and liabilities balance of $ 0.2 million , and four other co-produced film arrangements, the terms of which are similar. The accounting policies relating to co-produced film arrangements are disclosed in Notes 2(a) and 3(o) of the Company’s 2023 Form 10-K. For the three months ended March 31, 2024, an expense of $ 0.1 million , (2023 — $ 0.1 million ) attributable to transactions between the Company and other parties involved in the production of the films have been included in Costs and Expenses Applicable to Revenues ― Image Enhancement and Maintenance Services.

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows Supplemental Information	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Condensed Consolidated Statements of Cash Flows Supplemental Information	9. Condensed Consolidated Statements of Cash Flows – Supplemental Information (a) Changes in other operating assets and liabilities Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 (Increase) Decrease in: Financing receivables $ 1,481 $ ( 1,625 ) Prepaid expenses ( 525 ) ( 2,406 ) Variable consideration receivables ( 168 ) ( 3,440 ) Other assets 353 80 Increase (Decrease) in: Accounts payable ( 7,547 ) 513 Accrued and other liabilities ( 10,978 ) ( 1,466 ) $ ( 17,384 ) $ ( 8,344 ) (b) Depreciation and amortization Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Film assets $ 5,070 $ 3,452 Property, plant and equipment: Equipment supporting joint revenue sharing arrangements 5,695 5,772 Other property, plant and equipment (1) 2,252 2,287 Other intangible assets (2) 1,634 1,399 Other assets (3) 513 410 $ 15,164 $ 13,320 (1) Includes the amortization of laser projection systems, camera, and lens upgrades recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.1 million for the three months ended March 31, 2024 (2023 — $ 0.1 million ). (2) Includes the amortization of licenses and intellectual property recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.3 million for the three months ended March 31, 2024 (2023 — $ 0.3 million ). (3) Includes the amortization of lessee incentives provided by the Company to its customers under joint revenue sharing arrangements. (c) Write-downs, including asset impairments Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Inventories 15 6 Property, plant and equipment: Equipment supporting joint revenue sharing arrangements (1) 57 297 Other property, plant and equipment ( 7 ) 1 Other intangible assets 35 - Film assets 9 — $ 109 $ 304 (1) For the three months ended March 31, 2024, the Company recorded $ 0.1 million in write-downs (2023 ― $ 0.3 million in write-downs) in Costs and Expenses Applicable to Revenues ― Technology Rentals. These write-downs were mostly related to the write-down of leased xenon-based digital systems which were taken out of service in connection with customer upgrades to laser-based digital systems. (d) Significant non-cash investing activities Three months ended March 31, (In thousands of U.S. Dollars) 2024 2023 Net (decrease) increase in accruals related to: Investment in equipment supporting joint revenue sharing arrangements $ ( 469 ) $ ( 764 ) Acquisition of other intangible assets 5 ( 22 ) Purchases of property, plant and equipment (1) 78 548 $ ( 386 ) $ ( 238 ) (1) Refer to Note 4 for supplemental disclosure of non-cash leasing activities.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes (a) Income Tax Expense For the three months ended March 31, 2024, the Company recorded income tax expense of $ 5.2 million (2023 — $ 4.9 million ). The Company’s effective tax rate of 48.8 % for the three months ended March 31, 2024 is comparable to the same quarter in 2023. The Company’s effective tax rate for the three months ended March 31, 2024 differs from the Canadian statutory rate of 26.5 % primarily due to tax rate differences in foreign jurisdictions which was offset by an increase in the valuation allowance from continuing operations, withholding taxes and a shortfall in tax benefits related to share-based compensation. The Company’s effective tax rate of 48.8 % for the three months ended March 31, 2023 differs from the Canadian statutory rate of 26.5 % primarily due to tax rate differences in foreign jurisdictions which was offset by an increase in the valuation allowance and withholding taxes. As of March 31, 2024, the Company’s Condensed Consolidated Balance Sheets includes net deferred income tax assets of $ 7.7 million (December 31, 2023 — $ 8.0 million ). Realization of net deferred tax assets is dependent upon generation of sufficient taxable income in future years to obtain benefit from the reversal of temporary differences, net operating loss carryforwards and tax credit carryforwards. The amount of net deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. As of March 31, 2024, the Company’s Condensed Consolidated Balance Sheets also include deferred tax liabilities of $ 12.5 million (December 31, 2023 — $ 12.5 million ) primarily related to foreign withholding taxes associated with the remaining balance of unrepatriated historical earnings that will not be indefinitely reinvested outside of Canada. (b) Proposed Share Buyback Tax Bill C-59 includes draft legislation to introduce a 2 % tax on the net value of certain share buybacks by publicly traded Canadian-resident corporations. The tax applies to repurchases from current shareholders on or after January 1, 2024 with certain exceptions. The tax is imposed on the repurchasing corporation itself and will be included in the cost basis of the repurchased treasury stock. Based on the draft legislation, the Company has estimated a potential impact of $ 0.4 million for the first quarter of 2024. Recognition of the impact will occur once legislation has been enacted for financial reporting purposes.

Capital Stock and Reserves

Capital Stock and Reserves	3 Months Ended
Capital Stock and Reserves	Mar. 31, 2024
Equity [Abstract]
Capital Stock and Reserves	11. Capital Stock and Reserves (a) Share-Based Compensation For the three months ended March 31, 2024, share-based compensation expense totaled $ 4.7 million (2023 — $ 5.1 million ) and is reflected in the following accounts in the Condensed Consolidated Statements of Operations: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Costs and expenses applicable to revenues $ 228 $ 263 Selling, general and administrative expenses 4,337 5,196 Research and development 111 99 Executive transition costs — ( 499 ) $ 4,676 $ 5,059 The following table summarizes the Company’s share-based compensation expense by each award type: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Stock Options $ — $ 84 Restricted Share Units 2,742 3,365 Performance Stock Units 1,852 924 IMAX China Stock Options — 10 IMAX China Long Term Incentive Plan Restricted Share Units 27 541 IMAX China Long Term Incentive Plan Performance Stock Units 55 135 $ 4,676 $ 5,059 For the three months ended March 31, 2024, the Company's share-based compensation expense includes less than $ 0.1 million (2023 — $ nil ) related to restricted share units granted to non-employees which vested immediately upon granting. Stock Option Summary The following table summarizes the activity under the Company’s Stock Option Plan (“SOP”) and the IMAX Corporation Second Amended and Restated Long-Term Incentive Plan (as may be amended, “IMAX LTIP”) for the three months ended March 31, 2024 and 2023: Number of Shares Weighted Average Exercise 2024 2023 2024 2023 Stock options outstanding, beginning of period 3,329,422 3,604,739 $ 26.23 $ 26.36 Granted — — — — Exercised — — — — Forfeited — — — — Expired ( 607,114 ) ( 144,366 ) 28.15 31.85 Cancelled — — — — Stock options outstanding, end of period 2,722,308 3,460,373 25.80 26.13 Stock options exercisable, end of period 2,722,308 3,460,373 25.80 26.13 Stock options are no longer granted under the Company’s previously approved SOP. IMAX LTIP Restricted Share Units (“RSU”) Summary The following table summarizes the activity in respect of RSUs issued under the IMAX LTIP for the three months ended March 31, 2024 and 2023: Number of Awards Weighted Average Grant Date 2024 2023 2024 2023 RSUs outstanding, beginning of period 1,286,830 1,252,044 $ 18.53 $ 19.16 Granted 846,677 811,529 16.46 17.73 Vested and settled ( 609,016 ) ( 677,611 ) 19.04 18.70 Forfeited ( 16,315 ) ( 19,509 ) 19.12 19.80 RSUs outstanding, end of period 1,508,176 1,366,453 17.15 18.53 IMAX LTIP Performance Stock Units (“PSU”) Summary The Company grants two types of PSU awards, one which vests based on a combination of employee service and the achievement of certain Adjusted EBITDA targets and one which vests based on a combination of employee service and the achievement of total shareholder return (“TSR”) targets. The achievement of the Adjusted EBITDA and TSR targets in these PSUs is determined over a three-year performance period. At the conclusion of the three-year performance period, the number of PSUs that ultimately vest can range from 0 % to a maximum vesting opportunity of 175 % of the initial Adjusted EBITDA PSU award or 175 % of the initial TSR PSU award for awards issued in 2022 and 150 % of the initial TSR PSU award for awards issued in 2023, depending upon actual performance versus the established Adjusted EBITDA and TSR targets, respectively. The grant date fair value of PSUs with Adjusted EBITDA targets is equal to the closing price of the Company’s common shares on the date of grant or the average closing price of the Company’s common shares for five days prior to the date of grant. The grant date fair value of PSUs with TSR targets is determined on the grant date using a Monte Carlo Model. The compensation expense attributable to each type of PSU is recognized on a straight-line basis over the requisite service period. The fair value determined by the Monte Carlo Model is affected by the Company’s share price, as well as assumptions regarding a number of complex and subjective variables. These variables include, but are not limited to, market conditions as of the grant date, the Company’s expected share price volatility over the term of the awards, and other relevant data. The compensation expense is fixed on the date of grant based on the fair value of the PSUs granted. The amount and timing of compensation expense recognized for PSUs with Adjusted EBITDA targets is dependent upon management’s assessment of the likelihood of achieving these targets. If, as a result of management’s assessment, it is projected that a greater number of PSUs will vest than previously anticipated, a life-to-date adjustment to increase compensation expense is recorded in the period that such determination is made. Conversely, if, as a result of management’s assessment, it is projected that a lower number of PSUs will vest than previously anticipated, a life-to-date adjustment to decrease compensation expense is recorded in the period that such determination is made. The expense recognized in the three months ended March 31, 2024 and 2023 includes adjustments reflecting management’s estimate of the number of Adjusted EBITDA PSUs expected to vest. The following table summarizes the activity in respect of PSUs issued under the IMAX LTIP for the three months ended March 31, 2024 and 2023: Number of Awards Weighted Average Grant Date 2024 2023 2024 2023 PSUs outstanding, beginning of period 922,621 931,716 $ 19.16 $ 18.96 Granted (1) 578,855 580,118 17.98 17.68 Vested and settled (1) ( 316,226 ) ( 368,602 ) 19.71 16.92 Forfeited (2) ( 78,489 ) ( 208,648 ) 21.28 18.09 PSUs outstanding, end of period 1,106,761 934,584 18.32 19.16 (1) For the three months ended March 31, 2024, the balance of shares granted includes 135,511 additional shares, at a weighted average grant date fair value per share of $ 19.71 , as PSUs granted in 2021 with Adjusted EBITDA targets vested at 175 % on account of full achievement of the targets. (2) Forfeited PSUs include the TSR target awards issued in 2021 which did not vest as the market condition was not satisfied. For the three year period ending March 31, 2024, the Company recorded an expense of $ 1.5 million associated with these 68,850 shares which, despite the awards not vesting, will not be reversed into income. As of March 31, 2024, the maximum number of common shares that may be issued with respect to PSUs outstanding is 1,886,932 , assuming full achievement of the Adjusted EBITDA and TSR targets. (b) Issuer Purchases of Equity Securities On June 12, 2017, the Company announced that its Board of Directors approved a $ 200.0 million share repurchase program for its common shares that would have expired on June 30, 2020 , which was subsequently extended for a 12-month period in 2020, 2021, and 2023 and increased in the total share repurchase authority to $ 400.0 million. In 2023, the Company’s Board of Directors approved a 36-month extension to its share repurchase program through June 30, 2026. As of March 31, 2024, the Company has $ 150.8 million available under the program. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant to a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time. During the three months ended March 31, 2024, the Company repurchased 1,158,724 at an average price of $ 13.99 per share, for a total of $ 16.2 million , excluding commissions. During the three months ended March 31, 2023, the Company repurchased 109,477 common shares at an average price of $ 14.87 per share for a total of $ 1.6 million excluding commissions. The repurchases for the three months ended March 31, 2024 excludes repurchases of 108,393 shar es for a total of $ 1.6 million with trade dates in December 2023 (March 31, 2023 — 140,000 shares for a total of $ 2.0 million with trade dates in December 2022). During the three months ended March 31, 2024 and 2023, there w er e no shares purc hases in the administration of employee share-based plans. As of March 31, 2024 and December 31, 2023 , the IMAX LTIP trustee did no t hold any shares. Any shares held with the trustee are recorded at cost and are reported as a reduction against Capital Stock on the Company’s Condensed Consolidated Balance Sheets. In 2022, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10 % of the total number of issued shares as of June 23, 2022 ( 34,063,480 shares). This program expired on the date of the 2023 Annual General Meeting of IMAX China on June 6, 2023. During the 2023 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10 % of the total number of shares as of June 6, 2023 ( 33,959,314 shares). This program will be valid until the 2024 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time. During the three months ended March 31, 2024 and 2023, IMAX China did no t repurchase any commo n shares. The change in the non-controlling interest attributable to IMAX China as a result of common shares repurchased is recorded as a reduction to Non-Controlling Interests in the Condensed Consolidated Balance Sheets and the Condensed Consolidated Statements of Shareholders’ Equity. The difference between the consideration paid and the ownership interest obtained as a result of IMAX China share repurchases is recorded within Other Equity in the Condensed Consolidated Balance Sheets and the Condensed Consolidated Statements of Shareholders’ Equity. (c) Basic and Diluted Weighted Average Shares Outstanding The following table reconciles the denominator of the basic and diluted weighted average share computations: Three Months Ended March 31, 2024 2023 (In thousands) Issued and outstanding, beginning of period 53,260 54,149 Weighted average number of shares repurchased, net ( 759 ) ( 85 ) Weighted average number of shares outstanding - basic 52,501 54,064 Weighted average effect of potential common shares, if dilutive 905 927 Weighted average number of shares outstanding - diluted 53,406 54,991 For the three months ended March 31, 2024, the calculation of diluted weighted average shares outstanding excludes 3,824,411 , respectively (2023 — 4,260,382 ) that are issuable upon the vesting or exercise of share-based compensation including: (i) 729,150 RSUs (2023 — 620,553 ), (ii) 372,953 PSUs (2023 — 179,456 ) and (iii) 2,722,308 stock options (2023 — 3,460,373 ), as the effect would be anti-dilutive. The calculation of diluted weighted average shares outstanding for the three months ended March 31, 2024 and 2023 also excludes any shares potentially issuable upon the conversion of the Convertible Notes as the average market price of the Company’s common shares during the period of time they were outstanding was less than the approximate $ 28.75 per common share conversion price of the Convertible Notes. (d) Statutory Surplus Reserve Pursuant to the corporate law of the PRC, entities registered in the PRC are required to maintain certain statutory reserves, which are appropriated from after-tax profits (after offsetting accumulated losses from prior years), as reported in their respective statutory financial statements, before the declaration or payment of dividends to equity holders. All statutory reserves are created for specific purposes. The Company’s PRC subsidiaries are required to appropriate 10 % of statutory net profits to statutory surplus reserves, upon distribution of their after-tax profits. The Company’s PRC subsidiaries may discontinue the contribution when the aggregate sum of the statutory surplus reserve is more than 50 % of their registered capital. The statutory surplus reserve is non-distributable other than during liquidation and may only be used to fund losses from prior years, to expand production operations, or to increase the capital of the subsidiaries. In addition, the subsidiaries may make further contribution to the discretional surplus reserve using post-tax profits in accordance with resolutions of the Board of Directors. The statutory surplus reserve of RMB 36.4 million ($ 5.6 m illion) has reached 50 % of the Company’s PRC subsidiaries’ registered capital, and as such no further contributions to the reserve are required.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
Revenue from Contracts with Customers	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	12. Revenue from Contracts with Customers (a) Disaggregated Information About Revenue The following tables summarize the Company’s Revenues by reportable segment and revenue stream type for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 (In thousands of U.S. Dollars) Technology Sales Image Enhancement and Maintenance Services Technology Rentals Finance Income Total Content Solutions Segment Film Remastering and Distribution $ — $ 29,721 $ — $ — $ 29,721 Other Content Solutions — 4,292 — — 4,292 — 34,013 — — 34,013 Technology Products and Services Segment System Sales 7,118 — — — 7,118 System Rentals — — 18,601 — 18,601 Maintenance — 15,161 — — 15,161 Finance Income — — — 2,270 2,270 7,118 15,161 18,601 2,270 43,150 Sub-total for reportable segments 7,118 49,174 18,601 2,270 77,163 All Other 786 1,174 — — 1,960 Total $ 7,904 $ 50,348 $ 18,601 $ 2,270 $ 79,123 Three Months Ended March 31, 2023 (In thousands of U.S. Dollars) Technology Sales Image Enhancement and Maintenance Services Technology Rentals Finance Income Total Content Solutions Segment Film Remastering and Distribution $ — $ 30,073 $ — $ — $ 30,073 Other Content Solutions — 2,028 — — 2,028 — 32,101 — — 32,101 Technology Products and Services Segment System Sales 16,119 — — — 16,119 System Rentals — — 20,058 — 20,058 Maintenance — 13,551 — — 13,551 Finance Income — — — 1,939 1,939 16,119 13,551 20,058 1,939 51,667 Sub-total for reportable segments 16,119 45,652 20,058 1,939 83,768 All Other 1,703 1,475 — — 3,178 Total $ 17,822 $ 47,127 $ 20,058 $ 1,939 $ 86,946 For the three months ended March 31, 2024, revenues earned from Technology Sales include variable consideration of $ 1.7 million (2023 — $ 5.6 million). Variable consideration revenues represent an estimate of the contingent fees that may become due if certain annual minimum box office receipt thresholds are exceeded and are recorded as revenue in the period when the sale is recognized and may be adjusted in future periods based on actual results and changes in estimates over the term of the system agreement. For the three months ended March 31, 2024, revenues earned from leasing arrangements total $ 19.3 million (2023 — $ 22.4 million), including $ 18.6 million in Revenues ― Technology Rentals (2023 — $ 20.1 million), and $ 0.7 million in Revenues ― Technology Sales (2023 — $ 2.3 million). (b) Deferred Revenue IMAX System sale and lease arrangements include a requirement for the Company to provide maintenance services over the life of the arrangement, some of which are subject to a consumer price index adjustment each year. In circumstances where customers prepay the entire term’s maintenance fee based on the original arrangement, additional payments are due to the Company for the years after its extended warranty and maintenance obligations expire. Payments, upon renewal each year, are either prepaid or made in arrears and can vary in frequency from monthly to annually. As of March 31, 2024, $ 20.9 million of consideration has been deferred in relation to outstanding maintenance services to be provided on existing maintenance contracts (December 31, 2023 — $ 22.8 million ). Maintenance revenue is recognized evenly over the contract term, which coincides with the period over which maintenance services are provided. In the event of customer default, any payments made by the customer may be retained by the Company. In instances where the Company receives consideration prior to satisfying its performance obligations, the recognition of revenue is deferred. The majority of the deferred revenue balance relates to payments received by the Company for IMAX Systems where control of the system has not yet transferred to the customer. The deferred revenue balance related to an individual IMAX System increases as progress payments are made and is then derecognized when control of the system is transferred to the customer. Recognition dates are variable and depend on numerous factors, including some outside of the Company’s control. During the three months ended March 31, 2024, $ 12.1 million of revenue was recognized from the $ 67.1 million balance of deferred revenue as of December 31, 2023. During the three months ended March 31, 2023, $ 9.8 million of revenue was recognized from the $ 70.9 million balance of deferred revenue as of December 31, 2022 .

Segment Reporting

Segment Reporting	3 Months Ended
Segment Reporting	Mar. 31, 2024
Segment Reporting [Abstract]
Segment Reporting	13. Segment Reporting The Company’s Chief Executive Officer (“CEO”) is its Chief Operating Decision Maker (“CODM”), as such term is defined under U.S. GAAP. The CODM assesses segment performance based on segment revenues and segment gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company’s segments. The Company has the following reportable segments: (i) Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services. (ii) Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses. Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below. The following table presents the Company’s revenue and gross margin by reportable segment for the three months ended March 31, 2024 and 2023: Revenue (1) Gross Margin (In thousands of U.S. Dollars) 2024 2023 2024 2023 Content Solutions $ 34,013 $ 32,101 $ 22,099 $ 17,995 Technology Products and Services 43,150 51,667 23,584 29,891 Sub-total for reportable segments 77,163 83,768 45,683 47,886 All Other 1,960 3,178 1,206 2,165 Total $ 79,123 $ 86,946 $ 46,889 $ 50,051 (1) The Company’s largest customer represents 10 % of total Revenues for the three months ended March 31, 2024 (2023 — 9 %). No single customer comprises more than 10% of the Company’s total Accounts Receivable as of March 31, 2024 and December 31, 2023 . Geographic Information Revenue by geographic area is based on the location of the customer. Revenue related to IMAX Film Remastering process is presented based upon the geographic location of the IMAX System that exhibits the remastered films. IMAX Film Remastering and distribution revenue is generated through contractual relationships with studios and other third parties that may not be in the same geographical location as the IMAX Systems that exhibit the remastered films. The following table summarizes the Company’s revenues by geographic area for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 United States $ 26,604 $ 26,753 Greater China 21,453 26,566 Western Europe 14,191 10,168 Asia (excluding Greater China) 9,126 10,652 Canada 2,408 7,196 Latin America 1,460 1,603 Rest of the World 3,881 4,008 Total $ 79,123 $ 86,946 The United States and Greater China (which includes the mainland of the People’s Republic of China, Hong Kong, Macau, and Taiwan) each comprise greater than 10% of the Company’s total revenues for the three months ended March 31, 2024 and 2023 , respectively.

Employees Pension and Postretir

Employees Pension and Postretirement Benefits	3 Months Ended
Employees Pension and Postretirement Benefits	Mar. 31, 2024
Retirement Benefits [Abstract]
Employee's Pension and Postretirement Benefits	14. Employee ’s Pension and Postretirement Benefits (a) Defined Benefit Plan The Company has an unfunded defined benefit pension plan, the Supplemental Executive Retirement Plan (the “SERP” ), covering its CEO, Richard L. Gelfond. Under the terms of the SERP, if Mr. Gelfond ’s employment is terminated other than for cause (as defined in his employment agreement), he is entitled to receive SERP benefits in the form of a lump sum payment. SERP benefit payments to Mr. Gelfond are subject to a deferral for six months after the termination of his employment, at which time Mr. Gelfond will be entitled to receive interest on the deferred amount credited at the applicable federal rate for short-term obligations. Pursuant to an amendment to his employment agreement dated September 19, 2022, the term of Mr. Gelfond’ s employment was extended through December 31, 2025, although Mr. Gelfond has not informed the Company that he intends to retire at that time. Under the terms of his employment agreement, as amended, the total benefit payable to Mr. Gelfond under the SERP is fixed at $ 20.3 million. As of March 31, 2024, the Company’s projected benefit obligation for the SERP is $ 18.4 million (December 31, 2023 — $ 18.2 million ). For the three months ended March 31, 2024, the Company recorded interest costs of $ 0.2 million (2023 — $ 0.2 million) related to the SERP. The Company expects to recognize additional interest costs of $ 0.6 million related to the SERP during the remainder of 2024 . No contributions are expected to be made to the SERP in 2024. (b) Defined Contribution Pension Plan The Company also maintains defined contribution plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5 % of their base salary subject to certain prescribed maximums. During the three months ended March 31, 2024, the Company contributed and recorded expense of $ 0.4 million (2023 — $ 0.3 million) to its Canadian defined contribution plan and $ 0.3 million (2023 — $ 0.3 million) to its defined contr ibution employee plan under Section 401(k) of the U.S. Internal Revenue Code. (c) Postretirement Benefits – Executives The Company has an unfunded postretirement plan for Mr. Gelfond and Bradley J. Wechsler, former Chairman of the Company’s Board of Directors (the “Executive Postretirement Benefit Plan”). The Executive Postretirement Benefit Plan provides that the Company will maintain health benefits for Messrs. Gelfond and Wechsler until they become eligible for Medicare and, thereafter, the Company will provide Medicare supplemental coverage as selected by Messrs. Gelfond and Wechsler. Mr. Wechsler retired from the Company’s Board of Directors on June 9, 2021, and the Company is providing him with Medicare supplemental coverage or its cash equivalent. As of March 31, 2024, the Company’s postretirement benefits obligation under this plan is $ 0.5 million (December 31, 2023 — $ 0.5 million ). For the three months ended March 31, 2024, the Company has recorded an expense of less than $ 0.1 million (2023 — less than $ 0.1 million ) related to this plan. (d) Postretirement Benefits – Canadian Employees The Company has an unfunded postretirement plan for its Canadian employees meeting specific eligibility requirements. The Company will provide eligible participants, upon retirement, with health and welfare benefits. As of March 31, 2024, the Company’s postretirement benefits obligation under this plan is $ 0.8 million (December 31, 2023 — $ 1.0 million ). For the three months ended March 31, 2024, the Company has recorded an expense of less than $ 0.1 million (2023 — less than $ 0.1 million ) related to this plan. (e) Deferred Compensation Benefit Plan The Company maintained a nonqualified deferred compensation benefit plan (the “Retirement Plan”) covering the former CEO of IMAX Entertainment and Senior Executive Vice President of the Company. Under the terms of the Retirement Plan, the benefits were due to vest in full if the executive incurred a separation from service from the Company (as defined therein). In 2018, the executive incurred a separation from service from the Company, and as such, the Retirement Plan benefits became fully vested as of December 31, 2018. As of March 31, 2024, the benefit obligation related to the Retirement Plan was $ 4.1 million (December 31, 2023 — $ 4.1 million) and is recorded on the Company’s Condensed Consolidated Balance Sheets within Accrued and Other Liabilities. As the Retirement Plan is fully vested, the benefit obligation is measured at the present value of the benefits expected to be paid in the future with the accretion of interest recognized in the Condensed Consolidated Statements of Operations within Retirement Benefits Non-Service Expense. The Retirement Plan is funded by an investment in company-owned life insurance (“COLI”), which is recorded at its fair value on the Company’s Condensed Consolidated Balance Sheets within Prepaid Expenses. As of March 31, 2024, fair value of the COLI asset was $ 3.6 million (December 31, 2023 — $ 3.5 million ). Gains and losses resulting from changes in the cash surrender value of the COLI asset are recognized in the Condensed Consolidated Statements of Operations within Realized and Unrealized Investment Gains.

Financial Instruments

Financial Instruments	3 Months Ended
Financial Instruments	Mar. 31, 2024
Investments, All Other Investments [Abstract]
Financial Instruments	15. Financial Instruments (a) Financial Instruments The Company’s cash is invested with various major financial institutions. The Company’s $ 81.0 million balance of cash and cash equivalents as of March 31, 2024 (December 31, 2023 — $ 76.2 million ) includes $ 70.3 million in cash held outside of Canada (December 31, 2023 — $ 68.5 million ), of which $ 31.8 million was held in the PRC (December 31, 2023 — $ 30.0 million ). (b) Fair Value Measurements The carrying values of the Company’s Cash and Cash Equivalents, Accounts Receivable, Accounts Payable and Accrued Liabilities due within one year approximate their fair values due to the short-term maturity of these instruments. Including these instruments, the Company’s financial instruments consist of the following: As of March 31, 2024 As of December 31, 2023 (In thousands of U.S. Dollars) Carrying Estimated Carrying Estimated Level 1 Cash and cash equivalents (1) $ 81,017 $ 81,017 $ 76,200 $ 76,200 Level 2 Net financed sales receivables (2) $ 96,291 $ 96,313 $ 97,615 $ 96,500 Net investment in sales-type leases (2) 29,323 28,578 29,539 28,751 Equity securities (1) 1,000 1,000 1,000 1,000 COLI (4) 3,552 3,552 3,522 3,522 Foreign exchange contracts — designated forwards (3) ( 87 ) ( 87 ) 819 819 Wells Fargo Credit Facility borrowings (1) ( 69,000 ) ( 69,000 ) ( 24,000 ) ( 24,000 ) Federal Economic Development Loan (2) ( 2,426 ) ( 2,426 ) ( 2,498 ) ( 2,498 ) Convertible Notes (5) ( 230,000 ) ( 213,571 ) ( 230,000 ) ( 205,850 ) (1) Recorded at cost, which approximates fair value. (2) Fair value is estimated based on discounting future cash flows at currently available interest rates with comparable terms. (3) Fair value is determined using quoted prices in active markets. (4) Measured at cash surrender value, which approximates fair value. (5) Fair value is determined using quoted market prices that are observable in the market or that could be derived from observable market data. (c) Foreign Exchange Risk Management The Company is exposed to market risk from changes in foreign currency rates. A majority of the Company’s revenues is denominated in U.S. Dollars while a significant portion of its costs and expenses is denominated in Canadian Dollars. A portion of the Company’s net U.S. Dollar cash is converted to Canadian Dollars to fund Canadian Dollar expenses through the spot market. In China and Japan, the Company has ongoing operating expenses related to its operations in RMB and Japanese Yen, respectively. Net cash flows are converted to and from U.S. Dollars through the spot market. The Company also has cash receipts under leases denominated in RMB, Japanese Yen, Canadian Dollars and Euros which are converted to U.S. Dollars through the spot market. In addition, because IMAX films generate box office receipts in 89 different countries, unfavorable exchange rates between applicable local currencies and the U.S. Dollar could have an impact on box-office receipts and the Company’s revenues and results of operations. The Company’s policy is to not use any financial instruments for trading or other speculative purposes. The Company has entered into a series of foreign currency forward contracts to manage the risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests as of March 31, 2024 (the “Foreign Currency Hedges”), with settlement dates throughout 2024 and 2025 . Foreign currency derivatives are recognized and measured in the Condensed Consolidated Balance Sheets at fair value. Changes in the fair value (i.e., gains or losses) are recognized in the Condensed Consolidated Statements of Operations except for derivatives designated and qualifying as foreign currency cash flow hedging instruments. The Company currently has cash flow hedging instruments associated with Selling, General and Administrative Expenses. For foreign currency cash flow hedging instruments related to Selling, General and Administrative Expenses, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in Accumulated Other Comprehensive (Loss) Income (“AOCI”) and reclassified to the Condensed Consolidated Statements of Operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the Condensed Consolidated Statements of Operations. The notional value of foreign currency cash flow hedging instruments that qualify for hedge accounting as of March 31, 2024 was $ 34.8 million (December 31, 2023 — $ 40.6 million ). The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company’s Condensed Consolidated Financial Statements: Notional value of derivatives in foreign exchange contracts : March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Derivatives designated as hedging instruments: Foreign exchange contracts — Forwards $ 34,820 $ 40,563 Fair value of derivatives in foreign exchange contracts : March 31, December 31, (In thousands of U.S. Dollars) Balance Sheet Location 2024 2023 Derivatives designated as hedging instruments: Foreign exchange contracts — Forwards Other assets $ 104 $ 846 Accrued and other liabilities ( 191 ) ( 27 ) $ ( 87 ) $ 819 Derivatives in foreign currency hedging relationships are as follows : Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Foreign exchange contracts Derivative (Loss) Gain — Forwards Recognized in OCI (Effective Portion) $ ( 916 ) $ 134 Location of Derivative Loss Reclassified from AOCI Three Months Ended March 31, (In thousands of U.S. Dollars) (Effective Portion) 2024 2023 Foreign exchange contracts Selling, general and — Forwards administrative expenses $ ( 11 ) $ ( 339 ) The Company’s estimated net amount of the existing loss as of March 31, 2024 is $ 0.1 million , which is expected to be reclassified to the Condensed Consolidated Statements of Operations within the next twelve months. (d) Investments in Equity Securities The Company held an investment in the preferred shares of enterprises which meets the criteria for classification as an equity security carried at historical cost, net of impairment charges. The carrying value of the equity security investment was $ 1.0 million as of March 31, 2024 (December 31, 2023 — $ 1.0 million ) and is recorded within Other Assets in the Condensed Consolidated Balance Sheets.

Executive Transition Costs

Executive Transition Costs	3 Months Ended
Executive Transition Costs	Mar. 31, 2024
Executive Transition Costs [Abstract]
Executive Transition Costs	16. Executive Transition Costs In the first quarter of 2023 , the Company recognized executive transition costs of $ 1.4 million related to the departure of the President, IMAX Entertainment and Executive Vice President . No such costs were incurred in the first qua rter of 2024.

Non-Controlling Interests

Non-Controlling Interests	3 Months Ended
Non-Controlling Interests	Mar. 31, 2024
Temporary Equity Disclosure [Abstract]
Non-Controlling Interests	17. Non-Controlling Interests (a) IMAX China Non-Controlling Interest The Company indirectly owns 71.52 % of IMAX China, whose shares trade on the Hong Kong Stock Exchange (December 31, 2023 — 71.55 %). IMAX China remains a consolidated subsidiary of the Company. As of March 31, 2024, the balance of the Company’s non-controlling interest in IMAX China is $ 73.9 million (December 31, 2023 — $ 71.8 million). For the three months ended March 31, 2024, the net income attributable to the non-controlling interest in IMAX China is $ 2.2 million (2023 — $ 2.7 million ). (b) Other Non-Controlling Interest The Company’s Original Film Fund was established in 2014 to co-finance a portfolio of 10 original large-format films. The initial investment in the Original Film Fund was committed by a third party in the amount of $ 25.0 million, with the possibility of contributing additional funds. The Company has contributed $ 9.0 million to the Original Film Fund since 2014 and has reached its maximum contribution. As of March 31, 2024, the Original Film Fund has invested $ 22.3 million toward the development of original films. The related production, financing and distribution agreement includes put and call rights relating to change of control of the rights, title and interest in the co-financed pictures. (c) Non-Controlling Interest in Temporary Equity The following table summarizes the movement of the non-controlling interest in temporary equity related to the Original Film Fund for the three months ended March 31, 2024 and 2023: March 31, (In thousands of U.S. Dollars) 2024 2023 Beginning balance $ 658 $ 722 Net (loss) income ( 9 ) 9 Ending balance $ 649 $ 731

Related Party Transactions

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	18. Related Party Transactions On January 13, 2023, the Company, China International Communications Group (“CICG”), and Beach House Pictures Pte Ltd (“Beach House”) entered into an agreement to co-finance a documentary film, The Elephant Odyssey . A member of the Company’s Board of Directors and its Audit Committee, is the ultimate controlling shareholder of Blue Ant Media (“Blue Ant”), a media company that he co-founded in 2011. Blue Ant owns 70 % of Beach House. The total budget for the film is approximately $ 2.6 million, of which CICG is responsible for $ 0.3 million or 10 %. The Company and Beach House have agreed to finance $ 1.7 million or 75 % and $ 0.6 million or 25 % of the remaining budget, respectively. On February 8, 2024, Blue Ant sold 100 % of its interest in Beach House. The Company made payments of $ 1.0 million under the agreement up to March 31, 2024.

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounting Principles	Accounting Principles IMAX Corporation, together with its consolidated subsidiaries (the “Company” or “IMAX”), prepares its financial statements in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted from this report, as is permitted by such rules and regulations. In the Company’s opinion, the unaudited Condensed Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. The Condensed Consolidated Balance Sheet at December 31, 2023 was derived from the Company’s audited annual Consolidated Financial Statements, but does not contain all of the footnote disclosures included in the annual financial statements. The interim results presented in the Company’s Condensed Consolidated Statements of Operations are not necessarily indicative of results for a full year. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements included in the Company’s 2023 Annual Report on Form 10-K (the “2023 Form 10-K”), which should be consulted for a summary of the significant accounting policies utilized by the Company. These Condensed Consolidated Financial Statements are prepared following the same accounting policies disclosed in the 2023 Form 10-K.
Principles of Consolidation	Principles of Consolidation These Condensed Consolidated Financial Statements include the accounts of IMAX Corporation together with its consolidated subsidiaries, except for subsidiaries which have been identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. All intercompany accounts and transactions have been eliminated. The Company has evaluated its various variable interests to determine whether they are VIEs as required by U.S. GAAP. The Company has interests in ten film production companies, which have been identified as VIEs. The Company is the primary beneficiary of and consolidates five of these entities as it has the power to direct the activities that most significantly impact the economic performance of the VIE, and it has the obligation to absorb losses or the right to receive benefits from the respective VIE that could potentially be significant. The majority of the assets relating to these production companies are held by the IMAX Original Film Fund (the “Original Film Fund”) as described in Note 17 (b). The Company does not consolidate the other five film production companies because it does not have the power to direct their activities and it does not have the obligation to absorb the majority of the expected losses or the right to receive expected residual returns. The Company uses the equity method of accounting for these entities, which are not material to the Company’s Condensed Consolidated Financial Statements. A loss in the value of an equity method investment that is other than temporary is recognized as a charge in the Condensed Consolidated Statements of Operations. As of March 31, 2024 and December 31, 2023, total assets and liabilities of the Company’s consolidated VIEs are as follows: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Total assets $ 1,410 $ 1,425 Total liabilities $ 246 $ 246
Estimates and Assumptions	Estimates and Assumptions In preparing the Company’s Condensed Consolidated Financial Statements, management makes judgments in applying various accounting policies. The areas of policy judgment are consistent with those reported in Note 2(b) of the Company’s audited Consolidated Financial Statements included in its 2023 Form 10-K. Management also considers that its determination of operating and reporting segments represents an area of judgment, and has made this conclusion on the basis of what comprises the discrete financial information produced, but not provided to or used by its Chief Operating Decision Maker (“CODM”) to carry out this function. In addition, management makes assumptions about the Company’s future operating results and cash flows in deriving critical accounting estimates used in preparing the Condensed Consolidated Financial Statements. The significant estimates made by management include, but are not limited to: (i) the allocation of the transaction price in an IMAX System arrangement to distinct performance obligations; (ii) the amount of variable consideration to be earned on sales of IMAX Systems based on projections of future box office performance; (iii) expected credit losses on accounts receivable, financing receivables, and variable consideration receivables; (iv) provisions for the write-down of excess and obsolete inventory; (v) the fair values of the reporting units used in assessing the recoverability of goodwill; (vi) the cash flow projections used in testing the recoverability of long-lived assets such as the system equipment supporting joint revenue sharing arrangements; (vii) the economic lives of the system equipment supporting joint revenue sharing arrangements; (viii) the useful lives of intangible assets; (ix) the ultimate revenue forecasts used to test the recoverability of film assets; (x) the discount rates used to determine the present value of financing receivables and lease liabilities, as well as to determine the fair values of the Company’s reporting units for the purpose of assessing the recoverability of goodwill; (xi) pension plan assumptions; (xii) estimates related to the fair value and projected vesting of share-based payment awards; (xiii) the valuation of deferred income tax assets; and (xiv) reserves related to uncertain tax positions.
Recently Issued Accounting Standards Not Yet Adopted	Adoption of New Accounting Standards In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2023-06, “Disclosure Improvements: Codification Amendments in response to the SEC’s Disclosure Update and Simplification Initiative” (“ASU 2023-06”). ASU 2023-06 incorporates into U.S. GAAP certain presentation and disclosure requirements currently included in the SEC’s regulations. Each amendment will become effective prospectively from the date the SEC withdrawals the corresponding SEC regulatory requirement. The Company adopted ASU 2023-06 on January 1, 2024 . The adoption of ASU 2023-06 did no t have a material impact on the Company’s Consolidated Financial Statements. Recently Issued FASB Accounting Standard Codification Updates Not Yet Adopted In March 2020, the FASB issued Accounting Standards Update No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). The purpose of ASU 2020-04 is to provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. ASU 2020-04 is effective for all entities from the beginning of an interim period that includes the issuance date of the ASU 2020-04. In October 2022, the FASB extended the temporary accounting relief to December 31, 2024 from the current sunset date of December 31, 2022. As of March 31, 2024, the Company is not party to any third party contracts that reference the London Interbank Offered Rate (“LIBOR”). Accordingly, the Company does not expect ASU 2020-04 to have a material effect on its Consolidated Financial Statements. In November 2023, the FASB issued Accounting Standards Update No. 2023-07, Segment Reporting (Topic 820): Improvements to Reportable Segment Disclosures (“ASU 2023-07”). The purpose of ASU 2023-07 is to enhance the interim disclosure requirements by more closely aligning them with the annual requirements. ASU 2023-07 requires interim and annual disclosures to include information about the company's significant segment expenses. ASU 2023-07 will be effective for the Company’s year ended December 31, 2024 and all interim periods thereafter. The Company is in the process of evaluating the impact of ASU 2023-07 on its financial statements. In December 2023, the FASB issued Accounting Standard Update 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). The amendments in ASU 2023-09 improve the transparency of income tax disclosures by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation, and (ii) income taxes paid disaggregated by jurisdiction. ASU 2023-09 will be effective for the Company’s year ended December 31, 2025. The Company is in the process of evaluating the impact of ASU 2023-09 on its financial statements. In March 2024, the FASB issued Accounting Standard Update 2024-01, Compensation - Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”). ASU 2024-01 amends the guidance in Accounting Standard Codification 718 (“ASC 718”) by adding an illustrative example to demonstrate and clarify how to apply the scope guidance to determine whether profits interests and similar awards should be accounted for as share-based payment arrangement under ASC 718 or another standard. ASU 2024-01 will be effective for the Company’s period ended March 31, 2025. The Company is in the process of evaluating the impact of ASU 2024-01 on its financial statements. The Company considers the applicability and impact of all recently issued FASB accounting standard codification updates. Accounting standard updates that are not noted above were assessed and determined to be not applicable or not significant to the Company’s Condensed Consolidated Financial Statements for the period ended March 31, 2024 .
Credit Risk	The Company’s internal credit quality classifications are as follows: • Good Standing — The theater operator continues to be in good standing as payments and reporting are received on a regular basis. • Credit Watch — The theater operator has demonstrated a delay in payments, but continues to be in active communication with the Company. Theater operators placed on Credit Watch are subject to enhanced monitoring. In addition, depending on the size of the outstanding balance, length of time in arrears, and other factors, future transactions may need to be approved by management. These receivables are in better condition than those in the Pre-Approved Transactions Only category, but are not in as good condition as the receivables in the Good Standing category. • Pre-Approved Transactions Only — The theater operator has demonstrated a delay in payments with little or no communication with the Company. All services and shipments to the theater operator must be reviewed and approved by management. These receivables are in better condition than those in the All Transactions Suspended category, but are not in as good condition as the receivables in the Credit Watch category. In certain situations, a theater operator may be placed on nonaccrual status and all revenue recognition related to the theater may be suspended, including the accretion of Finance Income for Financing Receivables. • All Transactions Suspended — The theater operator is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater operator is classified within the All Transactions Suspended category, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are suspended, including the accretion of Finance Income for Financing Receivables. During the period when the accretion of Finance Income is suspended for Financing Receivables, any payments received from a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a reversal of the provision is recorded to the extent of the residual cash received. Once the collectability issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of Finance Income. When a customer’s aging exceeds 90 days, the Company’s policy is to perform an enhanced review to assess collectability of the theater’s past due accounts. The over 90 days past due category may be an indicator of potential impairment as up to 90 days outstanding is considered to be a reasonable time to resolve any issues. The Company develops an estimate of expected credit losses by class of receivable and customer type through a calculation that utilizes historical loss rates, which are then adjusted for specific receivables that are judged to have a higher-than-normal risk profile after considering management’s internal credit quality classifications. Additional credit loss provisions are also recorded taking into account macro-economic and industry risk factors. The write-off of any billed receivable balance requires the approval of management. Management’s judgments regarding expected credit losses are based on the facts available to management and involve estimates about the future. As a result, the Company’s judgments and associated estimates of credit losses may ultimately prove, with the benefit of hindsight, to be incorrect. The impacts of inflation, and rising interest rates may impact future credit losses. The Company will continue to monitor economic trends and conditions and portfolio performance and adjust its allowance for credit loss accordingly. Accounts Receivable Accounts receivable principally includes amounts currently due to the Company under IMAX System sale and sales-type lease arrangements, contingent fees owed by theater operators as a result of box office performance, and fees for maintenance services. Accounts receivable also includes amounts due to the Company from movie studios and other content creators principally for digitally remastering films into IMAX formats, as well as for film distribution and post-production services.
Lessee Leases	(a) IMAX Corporation as a Lessee The Company’s operating lease arrangements principally involve office and warehouse space. Office equipment is generally purchased outright. Leases with an initial term of less than 12 months are not recorded on the Condensed Consolidated Balance Sheets and the related lease expense is recognized on a straight-line basis over the lease term. Most of the Company’s leases include one or more options to renew, with renewal terms that can extend the lease term from one to five years or more. The Company has determined that it is reasonably certain that the renewal options on its warehouse leases will be exercised based on previous history, its current understanding of future business needs and its level of investment in leasehold improvements, among other factors. The incremental borrowing rate used in the calculation of the Company’s lease liabilities is based on the location of each leased property. None of the Company’s leases include options to purchase the leased property. The depreciable lives of right-of-use assets and related leasehold improvements are limited by the expected lease term. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants. In 2022, the Company entered into a finance lease arrangement involving equipment used to facilitate the delivery of live events to certain IMAX locations. The lease arrangement includes an option for the Company to purchase the equipment at the end of the lease term that is reasonably certain to be exercised. The resulting right-of-use assets are being depreciated from the lease commencement dates over the useful life of the underlying equipment. The incremental borrowing rate used in the calculation of the lease liabilities is based on the rate of interest the Company would have to pay to borrow on a collateralized basis over a similar term.
Lessor Leases	(b) IMAX Corporation as a Lessor The Company provides IMAX Systems to customers through long-term lease arrangements that for accounting purposes are classified as sales-type leases. Under these arrangements, in exchange for providing the IMAX System, the Company earns fixed upfront and ongoing consideration. Certain arrangements that are legal sales are also classified as sales-type leases as certain clauses within the arrangements limit transfer of title or provide the Company with conditional rights to the system. The customer’s rights under the Company’s sales-type lease arrangements are described in Note 2(o) of the Company’s audited Consolidated Financial Statements included in its 2023 Form 10-K. Under the Company’s sales-type lease arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s lease portfolio terms are typically non-cancellable for 10 to 20 year s w ith renewal provisions from inception. The Company’s sales-type lease arrangements do not contain a guarantee of residual value at the end of the lease term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and an extended warranty generally after the first year of the lease until the end of the lease term. The customer is responsible for obtaining insurance coverage for the IMAX System commencing on the date specified in the arrangement’s shipping terms and ending on the date the IMAX System is returned to the Company.
Commitments and Contingencies	The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. Management is required to assess the likelihood of any adverse judgments or outcomes related to these legal contingencies, as well as potential ranges of probable or reasonably possible losses. The Company records a provision for a liability when it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The determination of the amount of any liability recorded or disclosed is reviewed at least quarterly based on a careful analysis of each individual exposure with, in some cases, the assistance of outside legal counsel, taking into account the impact of negotiations, settlements, rulings, and other pertinent information related to the case. The amount of liabilities recorded or disclosed for these contingencies may change in the future due to changes in management’s judgments resulting from new developments or changes in settlement strategy. Any resulting adjustment to the liabilities recorded by the Company could have a material adverse effect on its results of operations, cash flows, and financial position in the period or periods in which such changes in judgment occur. The Company believes it has adequate provisions for any such matters. The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.
Segment Reporting	The Company has the following reportable segments: (i) Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services. (ii) Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Basis of Presentation (Tables)

Basis of Presentation (Tables)	3 Months Ended
Basis of Presentation (Tables)	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VIEs Total Assets and Liabilities	As of March 31, 2024 and December 31, 2023, total assets and liabilities of the Company’s consolidated VIEs are as follows: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Total assets $ 1,410 $ 1,425 Total liabilities $ 246 $ 246

Receivables (Tables)

Receivables (Tables)	3 Months Ended
Receivables (Tables)	Mar. 31, 2024
Receivables [Abstract]
Summary of Allowance For Credit Losses Related to Accounts Receivable	The following tables summarize the activity in the allowance for credit losses related to Accounts Receivable for the three months ended March 31, 2024 and 2023: Three Months Ended March 31,2024 (In thousands of U.S. Dollars) Theater Studios Other Total Beginning balance $ 14,355 $ 616 $ 1,006 $ 15,977 Current period (reversal) provision, net ( 94 ) 14 73 ( 7 ) Foreign exchange ( 14 ) — — ( 14 ) Ending balance $ 14,247 $ 630 $ 1,079 $ 15,956 Three Months Ended March 31, 2023 (In thousands of U.S. Dollars) Theater Studios Other Total Beginning balance $ 11,144 $ 1,699 $ 1,276 $ 14,119 Current period provision, net ( 265 ) 3 21 ( 241 ) Write-offs ( 115 ) — — ( 115 ) Foreign exchange 60 5 — 65 Ending balance $ 10,824 $ 1,707 $ 1,297 $ 13,828
Schedule of Financing Receivables	As of March 31, 2024 and December 31, 2023, financing receivables consist of the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Net investment in leases Gross minimum payments due under sales-type leases $ 30,215 $ 30,459 Unearned finance income ( 441 ) ( 467 ) Present value of minimum payments due under sales-type leases 29,774 29,992 Allowance for credit losses ( 451 ) ( 453 ) Net investment in leases 29,323 29,539 Financed sales receivables Gross minimum payments due under financed sales 133,511 135,684 Unearned finance income ( 27,604 ) ( 28,452 ) Present value of minimum payments due under financed sales 105,907 107,232 Allowance for credit losses ( 9,616 ) ( 9,617 ) Net financed sales receivables 96,291 97,615 Total financing receivables $ 125,614 $ 127,154 Net financed sales receivables due within one year $ 31,700 $ 32,031 Net financed sales receivables due after one year 64,591 65,584 Total financed sales receivables $ 96,291 $ 97,615
Schedule of Weighted-average Remaining Lease Term and Weighted-average Interest Rate	As of March 31, 2024 and December 31, 2023, the weighted-average remaining lease term and weighted-average interest rate associated with the Company’s sales-type lease arrangements and financed sale receivables, as applicable, are as follows: March 31, December 31, 2024 2023 Weighted-average remaining lease term (in years) Sales-type lease arrangements 8.1 8.3 Weighted-average interest rate Sales-type lease arrangements 7.56 % 7.88 % Financed sales receivables 9.01 % 8.97 %
Schedule of Net Investment In Leases by Credit Quality Indicator	The tables below provide information on the Company’s net investment in leases by credit quality indicator as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. (In thousands of U.S. Dollars) By Origination Year As of March 31, 2024 2024 2023 2022 2021 2020 Prior Total Net investment in leases: Credit quality classification: In good standing $ — $ 2,278 $ 3,072 $ 5,664 $ 1,771 $ 7,388 $ 20,173 Credit Watch — — — — — — — Pre-approved transactions — — 490 2,602 809 5,299 9,200 Transactions suspended — — — — — 401 401 Total net investment in leases $ — $ 2,278 $ 3,562 $ 8,266 $ 2,580 $ 13,088 $ 29,774 (In thousands of U.S. Dollars) By Origination Year As of December 31, 2023 2023 2022 2021 2020 2019 Prior Total Net investment in leases: Credit quality classification: In good standing $ 2,435 $ 3,262 $ 6,241 $ 2,173 $ 1,677 $ 1,138 $ 16,926 Credit Watch — 490 — — — 313 803 Pre-approved transactions — 3,462 1,182 5,221 1,997 11,862 Transactions suspended — — — — — 401 401 Total net investment in leases $ 2,435 $ 3,752 $ 9,703 $ 3,355 $ 6,898 $ 3,849 $ 29,992
Schedule of Financed Sales Receivables by Credit Quality Indicator	The tables below provide information on the Company’s financed sales receivables by credit quality indicator as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. (In thousands of U.S. Dollars) By Origination Year As of March 31, 2024 2024 2023 2022 2021 2020 Prior Total Financed sales receivables: Credit quality classification: In good standing $ 349 $ 10,849 $ 5,784 $ 6,001 $ 5,333 $ 49,560 $ 77,876 Credit Watch — — — — — 1,089 1,089 Pre-approved transactions — 471 342 2,904 1,513 8,968 14,198 Transactions suspended — 163 — 630 146 11,805 12,744 Total financed sales receivables $ 349 $ 11,483 $ 6,126 $ 9,535 $ 6,992 $ 71,422 $ 105,907 (In thousands of U.S. Dollars) By Origination Year As of December 31, 2023 2023 2022 2021 2020 2019 Prior Total Financed sales receivables: Credit quality classification: In good standing $ 6,660 5,921 5,961 5,415 8,058 44,870 $ 76,885 Credit Watch — 30 — — 317 796 1,143 Pre-approved transactions 607 313 2,619 1,455 2,084 8,508 15,586 Transactions suspended — 728 345 1,546 10,999 13,618 Total financed sales receivables $ 7,267 $ 6,264 $ 9,308 $ 7,215 $ 12,005 $ 65,173 $ 107,232
Schedule of Aging Analysis for Net Investment in Leases and Financed Sales Receivables	The following tables provide an aging analysis for the Company’s net investment in leases and financed sales receivables as of March 31, 2024 and December 31, 2023: As of March 31, 2024 (In thousands of U.S. Dollars) Accrued 30-89 90+ Billed Unbilled Recorded Allowance Net Net investment in leases $ 277 $ 451 $ 4,973 $ 5,701 $ 24,073 $ 29,774 $ ( 451 ) $ 29,323 Financed sales receivables 853 2,241 9,994 13,089 92,818 $ 105,907 ( 9,616 ) 96,291 Total $ 1,130 $ 2,692 $ 14,967 $ 18,790 $ 116,891 $ 135,681 $ ( 10,067 ) $ 125,614 As of December 31, 2023 (In thousands of U.S. Dollars) Accrued 30-89 90+ Billed Unbilled Recorded Allowance Net Net investment in leases $ 293 $ 212 $ 4,598 $ 5,103 $ 24,889 $ 29,992 $ ( 453 ) $ 29,539 Financed sales receivables 1,535 1,196 10,704 13,435 93,797 107,232 ( 9,617 ) 97,615 Total $ 1,828 $ 1,408 $ 15,302 $ 18,538 $ 118,686 $ 137,224 $ ( 10,070 ) $ 127,154
Schedule of Net Investment in Leases and Financed Sales Receivables with Billed Amounts Past Due Continues to Accrue Finance Income	The following tables provide information about the Company’s net investment in leases and financed sales receivables with billed amounts past due for which it continues to accrue finance income as of March 31, 2024 and December 31, 2023. The amounts disclosed for each credit quality classification are determined on a customer-by-customer basis and include both billed and unbilled amounts. As of March 31, 2024 (In thousands of U.S. Dollars) Accrued 30-89 Days 90+ Days Billed Unbilled Allowance Net Net investment in leases $ 240 $ 412 $ 4,973 $ 5,625 $ 22,036 $ ( 10 ) $ 27,651 Financed sales receivables 373 1,555 9,662 11,590 36,236 ( 1,046 ) 46,780 Total $ 613 $ 1,967 $ 14,635 $ 17,215 $ 58,272 $ ( 1,056 ) $ 74,431 As of December 31, 2023 (In thousands of U.S. Dollars) Accrued 30-89 Days 90+ Days Billed Unbilled Allowance Net Net investment in leases $ 259 $ 212 $ 4,598 $ 5,069 $ 22,651 $ ( 9 ) $ 27,711 Financed sales receivables 798 782 10,517 12,097 33,552 ( 1,198 ) 44,451 Total $ 1,057 $ 994 $ 15,115 $ 17,166 $ 56,203 $ ( 1,207 ) $ 72,162
Schedule of Net Investment in Leases and Financed Sales Receivables on Nonaccrual Status	The following table provides information about the Company’s net investment in leases and financed sales receivables that are on nonaccrual status as of March 31, 2024 and December 31, 2023: As of March 31, 2024 As of December 31, 2023 (In thousands of U.S. Dollars) Recorded Allowance Net Recorded Allowance Net Net investment in leases $ 401 $ ( 401 ) $ — $ 401 $ ( 401 ) $ — Net financed sales receivables 26,942 ( 8,882 ) 18,060 29,204 ( 8,884 ) 20,320 Total $ 27,343 $ ( 9,283 ) $ 18,060 $ 29,605 $ ( 9,285 ) $ 20,320
Summary of Allowance for Credit Losses Related to Net Investment in Leases and Financed Sales Receivables	The f ollowing tables summarize the activity in the allowance for credit losses related to the Company’s net investment in leases and financed sales receivables for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 Net Investment Financed (In thousands of U.S. Dollars) in Leases Sales Receivables Beginning balance $ 453 $ 9,617 Current period (reversal) provision, net 4 ( 4 ) Foreign exchange ( 6 ) 3 Ending balance $ 451 $ 9,616 Three Months Ended March 31, 2023 Net Investment Net Financed (In thousands of U.S. Dollars) in Leases Sales Receivables Beginning balance $ 776 $ 10,945 Current period (reversal) provision, net ( 2 ) 549 Foreign exchange 4 39 Ending balance $ 778 $ 11,533
Summary of Allowance For Credit Losses Related to Variable Consideration Receivables	The following table summarizes the activity in the Allowance for Credit Losses related to Variable Consideration Receivables for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 (In thousands of U.S. Dollars) Theater Theater Beginning balance $ 633 $ 610 Current period reversal, net 3 ( 86 ) Foreign exchange — 2 Ending balance $ 636 $ 526

Lease Arrangements (Tables)

Lease Arrangements (Tables)	3 Months Ended
Lease Arrangements (Tables)	Mar. 31, 2024
Leases [Abstract]
Components of Operating Lease Expense	For the three months ended March 31, 2024 and 2023, the components of lease expense recorded within Selling, General and Administrative Expenses are as follows: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Operating lease cost: Amortization of operating lease assets $ 522 $ 151 Interest on operating lease liabilities 175 724 Short-term and variable lease costs 78 204 Finance lease cost: Amortization of finance lease assets 100 100 Interest on finance lease liabilities 7 14 Total lease cost $ 882 $ 1,193
Supplemental Cash and Non-Cash Flow Information Related to Leases	For the three months ended March 31, 2024 and 2023, supplemental cash and non-cash information related to leases is as follows: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating leases $ 723 $ 971 Finance leases $ 28 $ — Supplemental disclosure of noncash leasing activities: Right-of-use assets obtained in exchange for operating lease obligations $ 260 $ 228 Right-of-use assets obtained in exchange for finance lease obligations $ — $ —
Lessee Operating Lease Balance Sheet Amounts and Lines	As of March 31, 2024 and December 31, 2023, supplemental balance sheet information related to leases is as follows: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Assets Balance Sheet Location Operating lease right-of-use assets Property, plant and equipment $ 10,263 $ 10,599 Finance lease right-of-use assets Property, plant and equipment $ 1,320 $ 1,420 Liabilities Balance Sheet Location Operating lease liabilities Accrued and other liabilities $ 12,353 $ 12,702 Finance lease liabilities Accrued and other liabilities $ 497 $ 518
Lessee Leases Weighted Average Remaining Lease Term and Weighted Average Interest Rate	As of March 31, 2024 and December 31, 2023, the weighted-average remaining lease term and weighted-average interest rate associated with the Company’s leases are as follows: March 31, December 31, 2024 2023 Operating leases: Weighted-average remaining lease term (years) 5.4 4.9 Weighted-average discount rate 5.83 % 5.85 % Finance leases: Weighted-average remaining lease term (years) 3.3 3.6 Weighted-average discount rate 6.00 % 6.00 %
Lessee Operating and Finance Lease, Maturity	As of March 31, 2024, the maturities of the Company’s operating and finance lease liabilities are as follows: (In thousands of U.S. Dollars) Operating Leases Finance Leases 2024 (nine months remaining) $ 1,998 $ 508 2025 2,528 — 2026 2,469 — 2027 2,468 — 2028 2,472 — Thereafter 2,429 — Total lease payments 14,364 508 Less: interest expense ( 2,011 ) ( 11 ) Present value of lease liabilities $ 12,353 $ 497
Schedule of Maturities of Lease Receivables	The following lease payments are expected to be received by the Company for its sales-type leases and joint revenue sharing arrangements in each of the next five years and thereafter following the March 31, 2024 balance sheet date: Sales-Type Joint Revenue (In thousands of U.S. Dollars) Leases Sharing Arrangements 2024 (nine months remaining) $ 2,433 $ 48 2025 3,112 27 2026 3,031 — 2027 2,965 — 2028 2,813 — Thereafter 15,664 — Total $ 30,018 $ 75

Inventories (Tables)

Inventories (Tables)	3 Months Ended
Inventories (Tables)	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventories	As of March 31, 2024 and December 31, 2023, Inventories consist of the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Raw materials $ 31,980 $ 27,660 Work-in-process 2,089 2,570 Finished goods 2,084 1,354 $ 36,153 $ 31,584

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
Borrowings (Tables)	Mar. 31, 2024
Debt Disclosure [Abstract]
Revolving Credit Facility Borrowings	As of March 31, 2024 and December 31, 2023, Revolving Credit Facility Borrowings, Net includes the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Wells Fargo Credit Facility borrowings $ 69,000 $ 24,000 Unamortized debt issuance costs ( 966 ) ( 1,076 ) Revolving Credit Facility Borrowings, net $ 68,034 $ 22,924
Summary of Convertible Notes and Other Borrowings, Net	As of March 31, 2024 and December 31, 2023, Convertible Notes and Other Borrowings, Net includes the following: March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Convertible Notes $ 230,000 $ 230,000 Unamortized discounts and debt issuance costs ( 2,991 ) ( 3,367 ) Convertible Notes, net 227,009 226,633 Federal Economic Development Loan 2,962 3,200 Unaccreted interest benefit ( 536 ) ( 702 ) Federal Economic Development Loan, net 2,426 2,498 Convertible Notes and Other Borrowings, net $ 229,435 $ 229,131

Condensed Consolidated Statem_7

Condensed Consolidated Statements of Operations Supplemental Information (Tables)	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Selling Expenses, Including Sales Commissions and Marketing and Other Expenses	The following table summarizes the Company’s selling expenses, including sales commissions and marketing and other, which are recognized within Costs and Expenses Applicable to Revenues in the Condensed Consolidated Statements of Operations, for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 2023 (In thousands of U.S. Dollars) Sales Marketing Sales Marketing Technology sales (1) $ 78 $ 166 $ 200 $ 16 Image enhancement and maintenance services (2) — 2,575 — 6,772 Technology rentals (3) 109 440 73 260 Total $ 187 $ 3,181 $ 273 $ 7,048 (1) Sales commissions paid prior to the recognition of the related revenue are deferred and recognized upon the client acceptance of the IMAX System. Direct advertising and marketing costs for each IMAX System are expensed as incurred. (2) Film exploitation costs, including advertising and marketing costs, are expensed as incurred. (3) Sales commissions related to joint revenue sharing arrangements accounted for operating leases are recognized in the month earned by the salesperson, which is typically the month in which the IMAX System is installed, and are subject to subsequent performance-based adjustments. Direct advertising and marketing costs for each IMAX System are expensed as incurred.

Condensed Consolidated Statem_8

Condensed Consolidated Statements of Cash Flows Supplemental Information (Tables)	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Summary of Changes in Other Operating Assets and Liabilities	Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 (Increase) Decrease in: Financing receivables $ 1,481 $ ( 1,625 ) Prepaid expenses ( 525 ) ( 2,406 ) Variable consideration receivables ( 168 ) ( 3,440 ) Other assets 353 80 Increase (Decrease) in: Accounts payable ( 7,547 ) 513 Accrued and other liabilities ( 10,978 ) ( 1,466 ) $ ( 17,384 ) $ ( 8,344 )
Summary of Depreciation and Amortization	Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Film assets $ 5,070 $ 3,452 Property, plant and equipment: Equipment supporting joint revenue sharing arrangements 5,695 5,772 Other property, plant and equipment (1) 2,252 2,287 Other intangible assets (2) 1,634 1,399 Other assets (3) 513 410 $ 15,164 $ 13,320 (1) Includes the amortization of laser projection systems, camera, and lens upgrades recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.1 million for the three months ended March 31, 2024 (2023 — $ 0.1 million ). (2) Includes the amortization of licenses and intellectual property recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.3 million for the three months ended March 31, 2024 (2023 — $ 0.3 million ). (3) Includes the amortization of lessee incentives provided by the Company to its customers under joint revenue sharing arrangements.
Write Downs, Including Asset Impairments	Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Inventories 15 6 Property, plant and equipment: Equipment supporting joint revenue sharing arrangements (1) 57 297 Other property, plant and equipment ( 7 ) 1 Other intangible assets 35 - Film assets 9 — $ 109 $ 304 (1) For the three months ended March 31, 2024, the Company recorded $ 0.1 million in write-downs (2023 ― $ 0.3 million in write-downs) in Costs and Expenses Applicable to Revenues ― Technology Rentals. These write-downs were mostly related to the write-down of leased xenon-based digital systems which were taken out of service in connection with customer upgrades to laser-based digital systems.
Significant Non-cash Investing Activities	Three months ended March 31, (In thousands of U.S. Dollars) 2024 2023 Net (decrease) increase in accruals related to: Investment in equipment supporting joint revenue sharing arrangements $ ( 469 ) $ ( 764 ) Acquisition of other intangible assets 5 ( 22 ) Purchases of property, plant and equipment (1) 78 548 $ ( 386 ) $ ( 238 ) (1) Refer to Note 4 for supplemental disclosure of non-cash leasing activities.

Capital Stock and Reserves (Tab

Capital Stock and Reserves (Tables)	3 Months Ended
Capital Stock and Reserves (Tables)	Mar. 31, 2024
Equity [Abstract]
Share-Based Compensation Expense	Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Costs and expenses applicable to revenues $ 228 $ 263 Selling, general and administrative expenses 4,337 5,196 Research and development 111 99 Executive transition costs — ( 499 ) $ 4,676 $ 5,059
Stock-based Compensation by Plan Type	The following table summarizes the Company’s share-based compensation expense by each award type: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Stock Options $ — $ 84 Restricted Share Units 2,742 3,365 Performance Stock Units 1,852 924 IMAX China Stock Options — 10 IMAX China Long Term Incentive Plan Restricted Share Units 27 541 IMAX China Long Term Incentive Plan Performance Stock Units 55 135 $ 4,676 $ 5,059
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the activity under the Company’s Stock Option Plan (“SOP”) and the IMAX Corporation Second Amended and Restated Long-Term Incentive Plan (as may be amended, “IMAX LTIP”) for the three months ended March 31, 2024 and 2023: Number of Shares Weighted Average Exercise 2024 2023 2024 2023 Stock options outstanding, beginning of period 3,329,422 3,604,739 $ 26.23 $ 26.36 Granted — — — — Exercised — — — — Forfeited — — — — Expired ( 607,114 ) ( 144,366 ) 28.15 31.85 Cancelled — — — — Stock options outstanding, end of period 2,722,308 3,460,373 25.80 26.13 Stock options exercisable, end of period 2,722,308 3,460,373 25.80 26.13
Restricted Stock Units Activity under the IMAX LTIP	The following table summarizes the activity in respect of RSUs issued under the IMAX LTIP for the three months ended March 31, 2024 and 2023: Number of Awards Weighted Average Grant Date 2024 2023 2024 2023 RSUs outstanding, beginning of period 1,286,830 1,252,044 $ 18.53 $ 19.16 Granted 846,677 811,529 16.46 17.73 Vested and settled ( 609,016 ) ( 677,611 ) 19.04 18.70 Forfeited ( 16,315 ) ( 19,509 ) 19.12 19.80 RSUs outstanding, end of period 1,508,176 1,366,453 17.15 18.53
Performance Stock Units Activity under the IMAX LTIP	The following table summarizes the activity in respect of PSUs issued under the IMAX LTIP for the three months ended March 31, 2024 and 2023: Number of Awards Weighted Average Grant Date 2024 2023 2024 2023 PSUs outstanding, beginning of period 922,621 931,716 $ 19.16 $ 18.96 Granted (1) 578,855 580,118 17.98 17.68 Vested and settled (1) ( 316,226 ) ( 368,602 ) 19.71 16.92 Forfeited (2) ( 78,489 ) ( 208,648 ) 21.28 18.09 PSUs outstanding, end of period 1,106,761 934,584 18.32 19.16 (1) For the three months ended March 31, 2024, the balance of shares granted includes 135,511 additional shares, at a weighted average grant date fair value per share of $ 19.71 , as PSUs granted in 2021 with Adjusted EBITDA targets vested at 175 % on account of full achievement of the targets. (2) Forfeited PSUs include the TSR target awards issued in 2021 which did not vest as the market condition was not satisfied. For the three year period ending March 31, 2024, the Company recorded an expense of $ 1.5 million associated with these 68,850 shares which, despite the awards not vesting, will not be reversed into income.
Basic and Diluted Per-share Computations	The following table reconciles the denominator of the basic and diluted weighted average share computations: Three Months Ended March 31, 2024 2023 (In thousands) Issued and outstanding, beginning of period 53,260 54,149 Weighted average number of shares repurchased, net ( 759 ) ( 85 ) Weighted average number of shares outstanding - basic 52,501 54,064 Weighted average effect of potential common shares, if dilutive 905 927 Weighted average number of shares outstanding - diluted 53,406 54,991

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
Revenue from Contracts with Customers (Tables)	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue by Segment	The following tables summarize the Company’s Revenues by reportable segment and revenue stream type for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 (In thousands of U.S. Dollars) Technology Sales Image Enhancement and Maintenance Services Technology Rentals Finance Income Total Content Solutions Segment Film Remastering and Distribution $ — $ 29,721 $ — $ — $ 29,721 Other Content Solutions — 4,292 — — 4,292 — 34,013 — — 34,013 Technology Products and Services Segment System Sales 7,118 — — — 7,118 System Rentals — — 18,601 — 18,601 Maintenance — 15,161 — — 15,161 Finance Income — — — 2,270 2,270 7,118 15,161 18,601 2,270 43,150 Sub-total for reportable segments 7,118 49,174 18,601 2,270 77,163 All Other 786 1,174 — — 1,960 Total $ 7,904 $ 50,348 $ 18,601 $ 2,270 $ 79,123 Three Months Ended March 31, 2023 (In thousands of U.S. Dollars) Technology Sales Image Enhancement and Maintenance Services Technology Rentals Finance Income Total Content Solutions Segment Film Remastering and Distribution $ — $ 30,073 $ — $ — $ 30,073 Other Content Solutions — 2,028 — — 2,028 — 32,101 — — 32,101 Technology Products and Services Segment System Sales 16,119 — — — 16,119 System Rentals — — 20,058 — 20,058 Maintenance — 13,551 — — 13,551 Finance Income — — — 1,939 1,939 16,119 13,551 20,058 1,939 51,667 Sub-total for reportable segments 16,119 45,652 20,058 1,939 83,768 All Other 1,703 1,475 — — 3,178 Total $ 17,822 $ 47,127 $ 20,058 $ 1,939 $ 86,946

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
Segment Reporting (Tables)	Mar. 31, 2024
Segment Reporting [Abstract]
Segment Reporting Information by Reportable Segment	The following table presents the Company’s revenue and gross margin by reportable segment for the three months ended March 31, 2024 and 2023: Revenue (1) Gross Margin (In thousands of U.S. Dollars) 2024 2023 2024 2023 Content Solutions $ 34,013 $ 32,101 $ 22,099 $ 17,995 Technology Products and Services 43,150 51,667 23,584 29,891 Sub-total for reportable segments 77,163 83,768 45,683 47,886 All Other 1,960 3,178 1,206 2,165 Total $ 79,123 $ 86,946 $ 46,889 $ 50,051 (1) The Company’s largest customer represents 10 % of total Revenues for the three months ended March 31, 2024 (2023 — 9 %). No single customer comprises more than 10% of the Company’s total Accounts Receivable as of March 31, 2024 and December 31, 2023 .
Summary of Revenues By Geographic Area	The following table summarizes the Company’s revenues by geographic area for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 United States $ 26,604 $ 26,753 Greater China 21,453 26,566 Western Europe 14,191 10,168 Asia (excluding Greater China) 9,126 10,652 Canada 2,408 7,196 Latin America 1,460 1,603 Rest of the World 3,881 4,008 Total $ 79,123 $ 86,946

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
Financial Instruments (Tables)	Mar. 31, 2024
Derivative Instruments Gain Loss [Line Items]
Fair Value of Financial Instruments	The carrying values of the Company’s Cash and Cash Equivalents, Accounts Receivable, Accounts Payable and Accrued Liabilities due within one year approximate their fair values due to the short-term maturity of these instruments. Including these instruments, the Company’s financial instruments consist of the following: As of March 31, 2024 As of December 31, 2023 (In thousands of U.S. Dollars) Carrying Estimated Carrying Estimated Level 1 Cash and cash equivalents (1) $ 81,017 $ 81,017 $ 76,200 $ 76,200 Level 2 Net financed sales receivables (2) $ 96,291 $ 96,313 $ 97,615 $ 96,500 Net investment in sales-type leases (2) 29,323 28,578 29,539 28,751 Equity securities (1) 1,000 1,000 1,000 1,000 COLI (4) 3,552 3,552 3,522 3,522 Foreign exchange contracts — designated forwards (3) ( 87 ) ( 87 ) 819 819 Wells Fargo Credit Facility borrowings (1) ( 69,000 ) ( 69,000 ) ( 24,000 ) ( 24,000 ) Federal Economic Development Loan (2) ( 2,426 ) ( 2,426 ) ( 2,498 ) ( 2,498 ) Convertible Notes (5) ( 230,000 ) ( 213,571 ) ( 230,000 ) ( 205,850 ) (1) Recorded at cost, which approximates fair value. (2) Fair value is estimated based on discounting future cash flows at currently available interest rates with comparable terms. (3) Fair value is determined using quoted prices in active markets. (4) Measured at cash surrender value, which approximates fair value. (5) Fair value is determined using quoted market prices that are observable in the market or that could be derived from observable market data.
Notional Amount of Derivative	The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company’s Condensed Consolidated Financial Statements: Notional value of derivatives in foreign exchange contracts : March 31, December 31, (In thousands of U.S. Dollars) 2024 2023 Derivatives designated as hedging instruments: Foreign exchange contracts — Forwards $ 34,820 $ 40,563
Fair Value of Foreign Exchange Contracts	Fair value of derivatives in foreign exchange contracts : March 31, December 31, (In thousands of U.S. Dollars) Balance Sheet Location 2024 2023 Derivatives designated as hedging instruments: Foreign exchange contracts — Forwards Other assets $ 104 $ 846 Accrued and other liabilities ( 191 ) ( 27 ) $ ( 87 ) $ 819
Derivatives in Foreign Currency Hedging Relationships	Derivatives in foreign currency hedging relationships are as follows : Three Months Ended March 31, (In thousands of U.S. Dollars) 2024 2023 Foreign exchange contracts Derivative (Loss) Gain — Forwards Recognized in OCI (Effective Portion) $ ( 916 ) $ 134 Location of Derivative Loss Reclassified from AOCI Three Months Ended March 31, (In thousands of U.S. Dollars) (Effective Portion) 2024 2023 Foreign exchange contracts Selling, general and — Forwards administrative expenses $ ( 11 ) $ ( 339 )

Non-Controlling Interests (Tabl

Non-Controlling Interests (Tables)	3 Months Ended
Non-Controlling Interests (Tables)	Mar. 31, 2024
Temporary Equity Disclosure [Abstract]
Summary of Movement of the Non-controlling Interest in Temporary Equity Related to Original Film Fund	The following table summarizes the movement of the non-controlling interest in temporary equity related to the Original Film Fund for the three months ended March 31, 2024 and 2023: March 31, (In thousands of U.S. Dollars) 2024 2023 Beginning balance $ 658 $ 722 Net (loss) income ( 9 ) 9 Ending balance $ 649 $ 731

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Details)	3 Months Ended
Basis of Presentation - Additional Information (Details)	Mar. 31, 2024
Variable Interest Entity [Line Items]
Number of variable interest entities	ten
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Number of variable interest entities primary beneficiary	five
Variable Interest Entity, Not Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Number of variable interest entities not a primary beneficiary	five

Basis of Presentation - VIEs To

Basis of Presentation - VIEs Total Assets and Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Variable Interest Entity, Consolidated, Carrying Amount, Total Assets	$ 824,140	$ 814,669
Variable Interest Entity, Consolidated, Carrying Amount, Total Liabilities	490,761	469,080
Variable Interest Entity, Primary Beneficiary [Member]
Variable Interest Entity [Line Items]
Variable Interest Entity, Consolidated, Carrying Amount, Total Assets	1,410	1,425
Variable Interest Entity, Consolidated, Carrying Amount, Total Liabilities	$ 246	$ 246

New Accounting Standards and _2

New Accounting Standards and Accounting Changes - Additional Information (Details) - ASU 2023-06	Mar. 31, 2024
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Jan. 01, 2024
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]	true

Receivables - Additional Inform

Receivables - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Current Expected Credit Losses [Line Items]
Finance Income related to the financed sales receivables in nonaccrual status	$ 0.4	$ 0.1
Finance income related to net investment in leases with billed amounts past due	0.6
Finance income related to financed sale receivables with billed amounts past due	0.5	0.8
Net Financed Sales Receivables [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses		0.6
Maximum [Member]
Current Expected Credit Losses [Line Items]
Finance income related to net investment in leases with billed amounts past due		0.1
Maximum [Member] \| Net Investment in Leases [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses	(0.1)	0.1
Maximum [Member] \| Net Financed Sales Receivables [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses	(0.1)
Theatre Operators [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses, variable consideration receivables		(0.1)
Theatre Operators [Member] \| Maximum [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses, variable consideration receivables	0.1
Theatre And Foreign Movie Studio [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses, accounts receivables		$ (0.4)
Theatre And Foreign Movie Studio [Member] \| Maximum [Member]
Current Expected Credit Losses [Line Items]
Increase (decrease) in allowance for current expected credit losses, accounts receivables	$ (0.1)

Receivables - Summary of Allowa

Receivables - Summary of Allowance For Credit Losses Related to Accounts Receivable (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts Receivable Allowance For Credit Loss [Line Items]
Beginning balance	$ 15,977	$ 14,119
Current period (reversal) provision, net	(7)	(241)
Write-offs		(115)
Foreign exchange	(14)	65
Ending balance	15,956	13,828
Theatre Operators [Member]
Accounts Receivable Allowance For Credit Loss [Line Items]
Beginning balance	14,355	11,144
Current period (reversal) provision, net	(94)	(265)
Write-offs		(115)
Foreign exchange	(14)	60
Ending balance	14,247	10,824
Studios [Member]
Accounts Receivable Allowance For Credit Loss [Line Items]
Beginning balance	616	1,699
Current period (reversal) provision, net	14	3
Foreign exchange		5
Ending balance	630	1,707
Other [Member]
Accounts Receivable Allowance For Credit Loss [Line Items]
Beginning balance	1,006	1,276
Current period (reversal) provision, net	73	21
Ending balance	$ 1,079	$ 1,297

Receivables - Schedule of Finan

Receivables - Schedule of Financing Receivables (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Net investment in leases
Gross minimum payments due under sales-type leases	$ 30,215	$ 30,459
Unearned finance income	(441)	(467)
Present value of minimum payments due under sales-type leases	29,774	29,992
Allowance for credit losses	(451)	(453)
Net investment in leases	29,323	29,539
Financed sales receivables
Gross minimum payments due under financed sales	133,511	135,684
Unearned finance income	(27,604)	(28,452)
Present value of minimum payments due under financed sales	105,907	107,232
Allowance for credit losses	(9,616)	(9,617)
Net financed sales receivables	96,291	97,615
Total financing receivables	125,614	127,154
Net financed sales receivables due within one year	31,700	32,031
Net financed sales receivables due after one year	64,591	65,584
Net financed sales receivables	$ 96,291	$ 97,615

Receivables - Schedule of Weigh

Receivables - Schedule of Weighted-average Remaining Lease Term and Weighted-average Interest Rate (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Weighted-average remaining lease term (in years)
Sales-type lease arrangements	8 years 1 month 6 days	8 years 3 months 18 days
Weighted-average interest rate
Sales-type lease arrangements	7.56%	7.88%
Financed sales receivables	9.01%	8.97%

Receivables - Schedule of Net I

Receivables - Schedule of Net Investment In Leases by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Net Investment In Lease Credit Quality Indicator [Line Items]
Net investment leases, By Origination Year, Current fiscal year		$ 2,435
Net investment leases, By Origination Year, Before latest fiscal year	$ 2,278	3,752
Net investment leases, By Origination Year, Two years before latest fiscal year	3,562	9,703
Net investment leases, By Origination Year, Three years before latest fiscal year	8,266	3,355
Net investment leases, By Origination Year, Four years before latest fiscal year	2,580	6,898
Net investment leases, By Origination Year, Prior	13,088	3,849
Net Investment in Lease, Total	29,774	29,992
In Good Standing [Member]
Net Investment In Lease Credit Quality Indicator [Line Items]
Net investment leases, By Origination Year, Current fiscal year		2,435
Net investment leases, By Origination Year, Before latest fiscal year	2,278	3,262
Net investment leases, By Origination Year, Two years before latest fiscal year	3,072	6,241
Net investment leases, By Origination Year, Three years before latest fiscal year	5,664	2,173
Net investment leases, By Origination Year, Four years before latest fiscal year	1,771	1,677
Net investment leases, By Origination Year, Prior	7,388	1,138
Net Investment in Lease, Total	20,173	16,926
Credit Watch [Member]
Net Investment In Lease Credit Quality Indicator [Line Items]
Net investment leases, By Origination Year, Before latest fiscal year		490
Net investment leases, By Origination Year, Prior		313
Net Investment in Lease, Total		803
Pre-Approved Transactions [Member]
Net Investment In Lease Credit Quality Indicator [Line Items]
Net investment leases, By Origination Year, Two years before latest fiscal year	490	3,462
Net investment leases, By Origination Year, Three years before latest fiscal year	2,602	1,182
Net investment leases, By Origination Year, Four years before latest fiscal year	809	5,221
Net investment leases, By Origination Year, Prior	5,299	1,997
Net Investment in Lease, Total	9,200	11,862
Transactions Suspended [Member]
Net Investment In Lease Credit Quality Indicator [Line Items]
Net investment leases, By Origination Year, Prior	401	401
Net Investment in Lease, Total	$ 401	$ 401

Receivables - Schedule of Fin_2

Receivables - Schedule of Financed Sales Receivables by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, By Origination Year, Current fiscal year	$ 349	$ 7,267
Financed sales receivables, By Origination Year, Before lastest fiscal year	11,483	6,264
Financed sales receivables, By Origination Year, Two year before latest fiscal year	6,126	9,308
Financed sales receivables, By Origination Year, Three year before latest fiscal year	9,535	7,215
Financed sales receivables, By Origination Year, Four year before latest fiscal year	6,992	12,005
Financed sales receivables, By Origination Year, Prior	71,422	65,173
Financed sales receivables, Total	135,681	137,224
Financing Receivable [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, Total	105,907	107,232
In Good Standing [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, By Origination Year, Current fiscal year	349	6,660
Financed sales receivables, By Origination Year, Before lastest fiscal year	10,849	5,921
Financed sales receivables, By Origination Year, Two year before latest fiscal year	5,784	5,961
Financed sales receivables, By Origination Year, Three year before latest fiscal year	6,001	5,415
Financed sales receivables, By Origination Year, Four year before latest fiscal year	5,333	8,058
Financed sales receivables, By Origination Year, Prior	49,560	44,870
In Good Standing [Member] \| Financing Receivable [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, Total	77,876	76,885
Credit Watch [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, By Origination Year, Before lastest fiscal year		30
Financed sales receivables, By Origination Year, Four year before latest fiscal year		317
Financed sales receivables, By Origination Year, Prior	1,089	796
Credit Watch [Member] \| Financing Receivable [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, Total	1,089	1,143
Pre-Approved Transactions [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, By Origination Year, Current fiscal year		607
Financed sales receivables, By Origination Year, Before lastest fiscal year	471	313
Financed sales receivables, By Origination Year, Two year before latest fiscal year	342	2,619
Financed sales receivables, By Origination Year, Three year before latest fiscal year	2,904	1,455
Financed sales receivables, By Origination Year, Four year before latest fiscal year	1,513	2,084
Financed sales receivables, By Origination Year, Prior	8,968	8,508
Pre-Approved Transactions [Member] \| Financing Receivable [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, Total	14,198	15,586
Transactions Suspended [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, By Origination Year, Before lastest fiscal year	163
Financed sales receivables, By Origination Year, Two year before latest fiscal year		728
Financed sales receivables, By Origination Year, Three year before latest fiscal year	630	345
Financed sales receivables, By Origination Year, Four year before latest fiscal year	146	1,546
Financed sales receivables, By Origination Year, Prior	11,805	10,999
Transactions Suspended [Member] \| Financing Receivable [Member]
Financing Receivable Recorded Investment [Line Items]
Financed sales receivables, Total	$ 12,744	$ 13,618

Receivables - Schedule of Aging

Receivables - Schedule of Aging Analysis for Net Investment in Leases and Financed Sales Receivables (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	$ 18,790	$ 18,538
Unbilled	116,891	118,686
Financed sales receivables, Total	135,681	137,224
Allowance for Credit Losses	(10,067)	(10,070)
Total financing receivables	125,614	127,154
Net Investment in Leases [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	5,701	5,103
Unbilled	24,073	24,889
Financed sales receivables, Total	29,774	29,992
Allowance for Credit Losses	(451)	(453)	$ (778)	$ (776)
Total financing receivables	29,323	29,539
Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	13,089	13,435
Unbilled	92,818	93,797
Financed sales receivables, Total	105,907	107,232
Allowance for Credit Losses	(9,616)	(9,617)	$ (11,533)	$ (10,945)
Total financing receivables	96,291	97,615
Accrued and Current [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	1,130	1,828
Accrued and Current [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	277	293
Accrued and Current [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	853	1,535
30 to 89 Days Past Due [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	2,692	1,408
30 to 89 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	451	212
30 to 89 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	2,241	1,196
Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	14,967	15,302
Equal To Greater Than 90 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	4,973	4,598
Equal To Greater Than 90 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Current And Past Due [Line Items]
Billed	$ 9,994	$ 10,704

Receivables - Schedule of Net_2

Receivables - Schedule of Net Investment in Leases and Financed Sales Receivables with Billed Amounts Past Due Continues to Accrue Finance Income (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	$ 18,790	$ 18,538
Unbilled	116,891	118,686
Allowance for Credit Losses	(10,067)	(10,070)
Total financing receivables	125,614	127,154
Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	5,701	5,103
Unbilled	24,073	24,889
Allowance for Credit Losses	(451)	(453)	$ (778)	$ (776)
Total financing receivables	29,323	29,539
Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	13,089	13,435
Unbilled	92,818	93,797
Allowance for Credit Losses	(9,616)	(9,617)	$ (11,533)	$ (10,945)
Total financing receivables	96,291	97,615
Accrued and Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	1,130	1,828
Accrued and Current [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	277	293
Accrued and Current [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	853	1,535
30 to 89 Days Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	2,692	1,408
30 to 89 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	451	212
30 to 89 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	2,241	1,196
Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	14,967	15,302
Equal To Greater Than 90 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	4,973	4,598
Equal To Greater Than 90 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	9,994	10,704
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	17,215	17,166
Unbilled	58,272	56,203
Allowance for Credit Losses	(1,056)	(1,207)
Total financing receivables	74,431	72,162
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	5,625	5,069
Unbilled	22,036	22,651
Allowance for Credit Losses	10	(9)
Total financing receivables	27,651	27,711
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	11,590	12,097
Unbilled	36,236	33,552
Allowance for Credit Losses	1,046	(1,198)
Total financing receivables	46,780	44,451
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Accrued and Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	613	1,057
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Accrued and Current [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	240	259
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Accrued and Current [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	373	798
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| 30 to 89 Days Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	1,967	994
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| 30 to 89 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	412	212
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| 30 to 89 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	1,555	782
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Equal To Greater Than 90 Days Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	14,635	15,115
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Equal To Greater Than 90 Days Past Due [Member] \| Net Investment in Leases [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	4,973	4,598
Net Investment in Leases and Financed Sale Receivables Continue to Accrue Finance Income [Member] \| Equal To Greater Than 90 Days Past Due [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Billed	$ 9,662	$ 10,517

Receivables - Schedule of Net_3

Receivables - Schedule of Net Investment in Leases and Financed Sales Receivables on Nonaccrual Status (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Financing Receivable Nonaccrual Status [Line Items]
Recorded Receivable	$ 27,343	$ 29,605
Allowance for Credit Losses	(9,283)	(9,285)
Net	18,060	20,320
Net Investment in Leases [Member]
Financing Receivable Nonaccrual Status [Line Items]
Recorded Receivable	401	401
Allowance for Credit Losses	(401)	(401)
Net Financed Sales Receivables [Member]
Financing Receivable Nonaccrual Status [Line Items]
Recorded Receivable	26,942	29,204
Allowance for Credit Losses	(8,882)	(8,884)
Net	$ 18,060	$ 20,320

Receivables - Summary of Allo_2

Receivables - Summary of Allowance for Credit Losses Related to Net Investment in Leases and Financed Sales Receivables (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	$ 10,070
Ending balance	10,067
Net Investment in Leases [Member]
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	453	$ 776
Current period (reversal) provision, net	4	(2)
Foreign exchange	(6)	4
Ending balance	451	778
Net Financed Sales Receivables [Member]
Financing Receivable Allowance For Credit Losses [Line Items]
Beginning balance	9,617	10,945
Current period (reversal) provision, net	(4)	549
Foreign exchange	3	39
Ending balance	$ 9,616	$ 11,533

Receivables - Summary of Allo_3

Receivables - Summary of Allowance For Credit Losses Related to Variable Consideration Receivables (Details) - Theatre Operators [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts Receivable Allowance For Credit Loss [Line Items]
Beginning balance	$ 633	$ 610
Current period provision (reversal), net	3	(86)
Foreign exchange		2
Ending balance	$ 636	$ 526

Lease Arrangements - Additional

Lease Arrangements - Additional Information (Details)	3 Months Ended
Lease Arrangements - Additional Information (Details)	Mar. 31, 2024 Lease
Leases [Line Items]
Lessee, operating lease description	The Company’s operating lease arrangements principally involve office and warehouse space. Office equipment is generally purchased outright. Leases with an initial term of less than 12 months are not recorded on the Condensed Consolidated Balance Sheets and the related lease expense is recognized on a straight-line basis over the lease term.
Lessee, operating lease, existence of option to extend term	true
Lessee, operating lease, existence of option to extend description	The Company has determined that it is reasonably certain that the renewal options on its warehouse leases will be exercised based on previous history, its current understanding of future business needs and its level of investment in leasehold improvements, among other factors.
Lessee, operating lease, assumptions for discount rate	The incremental borrowing rate used in the calculation of the Company’s lease liabilities is based on the location of each leased property.
Leases include options to purchase leased property	0
Lessee, operating lease, existence of residual value	false
Lessor, sales-type lease description	The Company provides IMAX Systems to customers through long-term lease arrangements that for accounting purposes are classified as sales-type leases. Under these arrangements, in exchange for providing the IMAX System, the Company earns fixed upfront and ongoing consideration. Certain arrangements that are legal sales are also classified as sales-type leases as certain clauses within the arrangements limit transfer of title or provide the Company with conditional rights to the system.
Minimum [Member]
Leases [Line Items]
Lessee, operating lease, renewal term	1 year
Sales-type lease, lease term	10 years
Non-cancellable term of joint revenue sharing arrangements	10 years
Maximum [Member]
Leases [Line Items]
Lessee, operating lease, renewal term	5 years
Sales-type lease, lease term	20 years
Non-cancellable term of joint revenue sharing arrangements	or longer

Lease Arrangements - Components

Lease Arrangements - Components of Operating Lease Expense (Details) - Selling, General and Administrative Expenses [Member] - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Line Items]
Amortization of operating lease assets	$ 522	$ 151
Interest on operating lease liabilities	175	724
Short-term and variable lease costs	78	204
Amortization of finance lease assets	100	100
Interest on finance lease liabilities	7	14
Total lease cost	$ 882	$ 1,193

Lease Arrangements - Supplement

Lease Arrangements - Supplemental Cash and Non-Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating leases	$ 723	$ 971
Finance leases	28
Supplemental Disclosure of Noncash Leasing Activities [Abstract]
Right-of-use assets obtained in exchange for operating lease obligations	$ 260	$ 228

Lease Arrangements - Lessee Ope

Lease Arrangements - Lessee Operating Lease Balance Sheet Amounts and Lines (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Line Items]
Operating lease right-of-use assets	$ 10,263	$ 10,599
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Finance lease right-of-use assets	$ 1,320	$ 1,420
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Operating lease liabilities	$ 12,353	$ 12,702
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities
Finance lease liabilities	$ 497	$ 518
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities

Lease Arrangements - Lessee Lea

Lease Arrangements - Lessee Leases Weighted Average Remaining Lease Term and Weighted Average Interest Rate (Details)	Mar. 31, 2024	Dec. 31, 2023
Operating Leases [Abstract]
Weighted-average remaining lease term (years)	3 years 3 months 18 days	3 years 7 months 6 days
Weighted-average discount rate	5.83%	5.85%
Finance Leases [Abstract]
Weighted-average remaining lease term (years)	5 years 4 months 24 days	4 years 10 months 24 days
Weighted-average discount rate	6%	6%

Lease Arrangements - Lessee O_2

Lease Arrangements - Lessee Operating and Finance Lease, Maturity (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Lessee, Operating Lease, Liability, to be Paid [Abstract]
2024 (nine months remaining)	$ 1,998
2025	2,528
2026	2,469
2027	2,468
2028	2,472
Thereafter	2,429
Total lease payments	14,364
Less: interest expense	(2,011)
Present value of operating lease liabilities	$ 12,353	$ 12,702
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Accrued and other liabilities	Accrued and other liabilities
Finance Lease, Liability, to be Paid [Abstract]
2024 (nine months remaining)	$ 508
Total lease payments	508
Less: interest expense	(11)
Present value of finance lease liabilities	$ 497	$ 518
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities

Lease Arrangements - Schedule o

Lease Arrangements - Schedule of Maturities of Lease Receivables (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Sales-type leases
2024 (nine months remaining)	$ 2,433
2025	3,112
2026	3,031
2027	2,965
2028	2,813
Thereafter	15,664
Total	30,018
Joint Revenue Sharing Arrangements
2024 (nine months remaining)	48
2025	27
Total	$ 75

Inventories - Inventories (Deta

Inventories - Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Inventories
Raw materials	$ 31,980	$ 27,660
Work-in-process	2,089	2,570
Finished goods	2,084	1,354
Total	$ 36,153	$ 31,584

Inventories - Additional Inform

Inventories - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Inventory [Line Items]
Finished goods inventory with title passed to customers	$ 600		$ 600
Write-downs for excess and damaged inventory	15	$ 6
Technology Sales [Member] \| Maximum [Member]
Inventory [Line Items]
Write-downs for excess and damaged inventory	$ 100	$ 100

Borrowings - Revolving Credit F

Borrowings - Revolving Credit Facility Borrowings, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Wells Fargo Credit Facility [Member]
Bank indebtedness [Line Items]
Borrowings	$ 69,000	$ 24,000
Revolving Credit Facility [Member]
Bank indebtedness [Line Items]
Unamortized debt issuance costs	(966)	(1,076)
Revolving Credit Facility Borrowings, net	$ 68,034	$ 22,924

Borrowings - Additional Informa

Borrowings - Additional Information (Details) $ / shares in Units, ¥ in Millions

3 Months Ended

12 Months Ended

48 Months Ended

Jan. 04, 2024

Mar. 19, 2021 USD ($)

May 29, 2019 USD ($)

Mar. 31, 2024 USD ($) $ / shares

Dec. 31, 2023 USD ($)

Dec. 31, 2022

Mar. 31, 2024 CNY (¥)

Dec. 31, 2023 CNY (¥)

Jun. 30, 2022 USD ($)

Jun. 30, 2022 CNY (¥)

Oct. 31, 2019 USD ($)

May 29, 2019 CAD ($)

Borrowings (Textual) [Abstract]

Credit facility description

On March 25, 2022, the Company entered into a Sixth Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as agent (the “Agent”), and a syndicate of lenders party thereto (the “Credit Agreement”), which extended the maturity date of the credit facility under the Credit Agreement (the “Credit Facility”) from June 28, 2023 to March 25, 2027. The Company’s obligations under the Credit Agreement are guaranteed by certain of the Company’s subsidiaries (the “Guarantors”), and are secured by first-priority security interests in substantially all of the assets of the Company and the Guarantors.

Credit facility maturity date

Mar. 25, 2027

Current borrowing capacity

$ 300,000,000

Line of credit facility covenant terms

The Credit Facility requires that the Company maintain a maximum Senior Secured Net Leverage Ratio (as defined in the Credit Agreement) of no greater than 3.25:1.00, on the last day of each Fiscal Quarter.

Convertible Notes [Member]

Borrowings (Textual) [Abstract]

Borrowings

$ 230,000,000

Debt instrument, principal amount

$ 230,000,000

Debt instrument, annual interest rate

0.50%

Proceeds from issuance of convertible notes, net

$ 223,700,000

Debt instrument, frequency of periodic interest payment

semi-annually

Debt instrument, payment terms

The Convertible Notes are senior unsecured obligations of the Company and bear interest at a rate of 0.500% per annum on the principal of $230.0 million, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on October 1, 2021.

Debt instrument, date of first required payment

Oct. 01, 2021

Debt instrument, maturity date

Apr. 01, 2026

Debt instrument, convertible, terms of conversion feature

Holders of the Convertible Notes have the right to convert their Convertible Notes in certain circumstances and during specified periods. Before January 1, 2026, holders of the Convertible Notes have the right to convert their Convertible Notes only upon the occurrence of certain events. From and after January 1, 2026, holders of the Convertible Notes may convert their Convertible Notes at any time at their election until the close of business on the second scheduled trading day immediately before the maturity date. Upon conversion, the Company will pay or deliver, as applicable, cash or a combination of cash (in an amount no less than the principal amount of the Convertible Notes being converted) and common shares, at its election, based on the applicable conversion rates. The initial conversion rate is 34.7766 common shares per $1,000 principal amount of Convertible Notes, which represents an initial conversion price of approximately $28.75 per common share, and is subject to adjustment upon the occurrence of certain events.

Debt instrument, initial conversion rate per $1,000 principal amount

34.7766

Convertible notes principal amount

$ 1,000

Debt instrument, initial conversion price | $ / shares

$ 28.75

Debt instrument, redemption, description

The Convertible Notes are redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after April 6, 2024 and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price for a specified period of time. In addition, calling any Convertible Notes for redemption will constitute a “make-whole fundamental change” with respect to such notes, in which case the conversion rate applicable to the conversion of such notes will be increased in certain circumstances if such notes are converted after they are called for redemption.

Debt instrument, redemption start date

Apr. 06, 2024

Convertible Notes [Member] | Call Option [Member]

Borrowings (Textual) [Abstract]

Cap price of capped call transactions | $ / shares

37.275

Percentage of premium of cap price over last reported sale price per common share on March 16, 2021

75%

Cost of capped call transactions

$ 19,100,000

Reduction to other equity

$ 19,100,000

Bank of China Facility [Member]

Borrowings (Textual) [Abstract]

Credit facility description

In June 2022, IMAX (Shanghai) Multimedia Technology Co., Ltd. (“IMAX Shanghai”), one of the Company’s majority-owned subsidiaries in China, renewed its unsecured revolving facility with Bank of China for up to 200.0 million Chinese Renminbi (“RMB”) ($28.2 million), including RMB 10.0 million ($1.4 million) for letters of guarantee, to fund ongoing working capital requirements (the “Bank of China Facility”).

Credit facility maturity date

Feb. 21, 2025

Current borrowing capacity

$ 28,200,000

¥ 200

Borrowings

$ 0

Effective interest rate

3.85%

Letters of guarantees borrowing capacity

1,400,000

Remaining borrowing capacity

$ 26,800,000

¥ 190

HSBC China Facility [Member]

Borrowings (Textual) [Abstract]

Current borrowing capacity

$ 28,200,000

¥ 200

Borrowings

$ 0

Effective interest rate

3.88%

Remaining borrowing capacity

$ 28,200,000

200

¥ 200

Federal Economic Development Loan Payable [Member]

Borrowings (Textual) [Abstract]

Debt instrument, fair value

2,426,000

2,498,000

Federal Economic Development Loan Payable [Member] | Interest Expense [Member]

Borrowings (Textual) [Abstract]

Interest accretion expense

100,000

Federal Economic Development Loan Payable [Member] | SSIMWAVE Inc. [Member]

Borrowings (Textual) [Abstract]

Debt instrument, annual interest rate

Percentage of contributions cover eligible and supported costs

35%

Contributions repayable months

36 months

60 months

Debt instrument repayment beginning month and year

2024-01

Foreign Exchange Facility [Member]

Borrowings (Textual) [Abstract]

Unrealized gain (loss) on outstanding foreign currency forward contracts

800,000

Notional Amount of arrangements entered into

34,800,000

40,600,000

Letter of Credit [Member] | Bank of China Facility [Member]

Borrowings (Textual) [Abstract]

Remaining borrowing capacity

1,400,000

¥ 9.8

NBC Facility [Member]

Borrowings (Textual) [Abstract]

Current borrowing capacity

$ 5,000,000

Remaining borrowing capacity

Wells Fargo Credit Facility [Member]

Borrowings (Textual) [Abstract]

Borrowings

69,000,000

24,000,000

Letters of credit or advance payment guarantees

$ 0

Line of credit facility covenant terms

The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit indebtedness, liens, asset sales, investments and restricted payments, in each case subject to negotiated exceptions and baskets. The Credit Agreement also contains customary representations, warranties and event of default provisions.

Debt instrument net leverage ratio

0.16

Interest rate description

Loans under the Credit Facility bear interest, at the Company’s option, at (i) Term Secure Overnight Financing Rate (“SOFR”), Eurocurrency Rate or Canadian Dollar Offered Rate (“CDOR”) plus a margin ranging from 1.00% to 1.75% per annum; or (ii) the U.S. base rate or the Canadian prime rate plus a margin ranging from 0.25% to 1.00% per annum, in each case depending on the Company’s total leverage ratio. In no event will Term SOFR, Eurocurrency Rate or CDOR Rate be less than 0.00% per annum.

Effective interest rate

6.93%

6.83%

Remaining borrowing capacity

$ 231,000,000

$ 276,000,000

Wells Fargo Credit Facility [Member] | Secure Overnight Financing Rate, Eurocurrency Rate or Canadian Dollar Offered Rate [Member]

Borrowings (Textual) [Abstract]

Interest rate margin percentage

1.50%

Interest rate maximum margin percentage

Minimum [Member]

Borrowings (Textual) [Abstract]

Borrowing capacity under uncommitted accordion feature

$ 140,000,000

Minimum [Member] | Convertible Notes [Member]

Borrowings (Textual) [Abstract]

Percentage of last reported sale price per common share against conversion price for specific period of time

130%

Minimum [Member] | Wells Fargo Credit Facility [Member] | Secure Overnight Financing Rate, Eurocurrency Rate or Canadian Dollar Offered Rate [Member]

Borrowings (Textual) [Abstract]

Interest rate margin percentage

Minimum [Member] | Wells Fargo Credit Facility [Member] | U.S. Base Rate or Canadian Prime Rate [Member]

Borrowings (Textual) [Abstract]

Interest rate margin percentage

0.25%

Maximum [Member]

Borrowings (Textual) [Abstract]

Borrowing capacity under uncommitted accordion feature

$ 440,000,000

Letters of guarantee outstanding

100,000

Maximum [Member] | Federal Economic Development Loan Payable [Member] | Interest Expense [Member]

Borrowings (Textual) [Abstract]

Interest accretion expense

$ 100,000

Maximum [Member] | Federal Economic Development Loan Payable [Member] | SSIMWAVE Inc. [Member]

Borrowings (Textual) [Abstract]

Debt instrument, principal amount

$ 3,100,000

$ 4,200,000

Maximum [Member] | Foreign Exchange Facility [Member]

Borrowings (Textual) [Abstract]

Unrealized gain (loss) on outstanding foreign currency forward contracts

$ 100,000

Maximum [Member] | Wells Fargo Credit Facility [Member]

Borrowings (Textual) [Abstract]

Debt instrument net leverage ratio

3.25

Unrestricted cash and cash equivalents held outside of People's Republic of China

$ 75,000,000

Maximum [Member] | Wells Fargo Credit Facility [Member] | Secure Overnight Financing Rate, Eurocurrency Rate or Canadian Dollar Offered Rate [Member]

Borrowings (Textual) [Abstract]

Interest rate margin percentage

1.75%

Maximum [Member] | Wells Fargo Credit Facility [Member] | U.S. Base Rate or Canadian Prime Rate [Member]

Borrowings (Textual) [Abstract]

Interest rate margin percentage

Borrowings - Summary of Convert

Borrowings - Summary of Convertible Notes and Other Borrowings, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Bank indebtedness [Line Items]
Revolving Credit Facility Borrowings, net	$ 229,435	$ 229,131
Convertible Notes and Other Borrowings, net	229,435	229,131
Convertible Notes [Member]
Bank indebtedness [Line Items]
Borrowings	230,000	230,000
Unamortized discounts and debt issuance costs	(2,991)	(3,367)
Revolving Credit Facility Borrowings, net	227,009	226,633
Federal Economic Development Loan [Member]
Bank indebtedness [Line Items]
Loans payable	2,962	3,200
Unaccreted interest benefit	(536)	(702)
Debt instrument, fair value, Total	$ 2,426	$ 2,498

Commitments, Contingencies an_2

Commitments, Contingencies and Guarantees - Additional Information (Details) - USD ($)	3 Months Ended	51 Months Ended	95 Months Ended
	Mar. 31, 2024	Mar. 27, 2008	Dec. 02, 2011	Dec. 31, 2023
Loss Contingencies [Line Items]
Final Award in favor of company		amount of $11.3 million, as well as an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid	$30,000 to cover the costs of the application
Final Award amount issued		$ 11,300,000
Final Award additional interest		$ 2,512
Final Award settlement cost			$ 30,000
Award inclusive of interest	$ 26,400,000
Product warranty accrual	200,000			$ 100,000
Indemnification of its directors/officers	0			$ 0
Other Indemnification	$ 0

Condensed Consolidated Statem_9

Condensed Consolidated Statements of Operations Supplemental Information - Summary of Selling Expenses, Including Sales Commissions and Marketing and Other Expenses (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Collaborative Arrangements [Line Items]
Sales Commissions		$ 187	$ 273
Marketing and Other		3,181	7,048
Technology Sales [Member]
Collaborative Arrangements [Line Items]
Sales Commissions	[1]	78	200
Marketing and Other	[1]	166	16
Image Enhancement and Maintenance Services [Member]
Collaborative Arrangements [Line Items]
Marketing and Other	[2]	2,575	6,772
Technology Rentals [Member]
Collaborative Arrangements [Line Items]
Sales Commissions	[3]	109	73
Marketing and Other	[3]	$ 440	$ 260

[1] Sales commissions paid prior to the recognition of the related revenue are deferred and recognized upon the client acceptance of the IMAX System. Direct advertising and marketing costs for each IMAX System are expensed as incurred. Film exploitation costs, including advertising and marketing costs, are expensed as incurred. Sales commissions related to joint revenue sharing arrangements accounted for operating leases are recognized in the month earned by the salesperson, which is typically the month in which the IMAX System is installed, and are subject to subsequent performance-based adjustments. Direct advertising and marketing costs for each IMAX System are expensed as incurred.

Condensed Consolidated State_10

Condensed Consolidated Statements of Operations Supplemental Information - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) Film	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Foreign Exchange
Foreign exchange translation gain (loss)	$ 300	$ 100
Collaborative Arrangements
Average percentage of the box-office receipts of the film for recovering digital re-mastering cost	12.50%
Revenue attributable to transactions arising between the company and its customers under IMAX film remastering and distribution arrangements	$ 29,700	30,100
Number of significant co-produced film arrangement \| Film	1
Number of other co-produced film arrangements \| Film	4
Variable Interest Entity, Consolidated, Carrying Amount, Total Assets	$ 824,140		$ 814,669
Variable Interest Entity, Consolidated, Carrying Amount, Total Liabilities	490,761		469,080
Amounts attributable to transactions between the company and other parties involved in the production of films included in costs and expenses	100	100
Variable Interest Entity, Primary Beneficiary [Member]
Collaborative Arrangements
Variable Interest Entity, Consolidated, Carrying Amount, Total Assets	1,410		1,425
Variable Interest Entity, Consolidated, Carrying Amount, Total Liabilities	246		$ 246
Retrospective adoption of ASC Topic 606, Revenue from Contracts with Customers [Member]
Collaborative Arrangements
Revenue attributable to transactions arising between the company and its customers under joint revenue sharing arrangements	$ 19,300	$ 20,100

Condensed Consolidated State_11

Condensed Consolidated Statements of Cash Flows Supplemental Information - Summary of Changes in Other Operating Assets and Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
(Increase) Decrease in:
Financing receivables	$ 1,481	$ (1,625)
Prepaid expenses	(525)	(2,406)
Variable consideration receivables	(168)	(3,440)
Other assets	353	80
Increase (Decrease) in:
Accounts payable	(7,547)	513
Accrued and other liabilities	(10,978)	(1,466)
Changes in other operating assets and liabilities	$ (17,384)	$ (8,344)

Condensed Consolidated State_12

Condensed Consolidated Statements of Cash Flows Supplemental Information - Summary of Depreciation and Amortization (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Summary of Depreciation and amortization
Film assets		$ 5,070	$ 3,452
Property, plant and equipment:
Equipment supporting joint revenue sharing arrangements		5,695	5,772
Other property, plant and equipment	[1]	2,252	2,287
Other intangible assets	[2]	1,634	1,399
Other assets	[3]	513	410
Depreciation and amortization		$ 15,164	$ 13,320

[1] Includes the amortization of laser projection systems, camera, and lens upgrades recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.1 million for the three months ended March 31, 2024 (2023 — $ 0.1 million ). Includes the amortization of licenses and intellectual property recorded in Research and Development on the Condensed Consolidated Statements of Operations of $ 0.3 million for the three months ended March 31, 2024 (2023 — $ 0.3 million ). Includes the amortization of lessee incentives provided by the Company to its customers under joint revenue sharing arrangements.

Condensed Consolidated State_13

Condensed Consolidated Statements of Cash Flows Supplemental Information - Summary of Depreciation and Amortization (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental Cash Flow Elements [Abstract]
Amortization of property, plant and equipment net in research and development	$ 0.1	$ 0.1
Amortization of intangible assets net in research and development	$ 0.3	$ 0.3

Condensed Consolidated State_14

Condensed Consolidated Statements of Cash Flows Supplemental Information - Write Downs, Including Asset Impairments (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Write-downs
Inventories		$ 15	$ 6
Equipment supporting joint revenue sharing arrangements	[1]	57	297
Other property, plant and equipment		(7)	1
Other intangible assets		35
Film assets		9
Write-downs		$ 109	$ 304

[1] For the three months ended March 31, 2024, the Company recorded $ 0.1 million in write-downs (2023 ― $ 0.3 million in write-downs) in Costs and Expenses Applicable to Revenues ― Technology Rentals. These write-downs were mostly related to the write-down of leased xenon-based digital systems which were taken out of service in connection with customer upgrades to laser-based digital systems.

Condensed Consolidated State_15

Condensed Consolidated Statements of Cash Flows Supplemental Information - Write-downs, Net of Recoveries (Parenthetical) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental Cash Flow Elements [Line Items]
Theater system components written off in Costs and expenses	$ 0.1	$ 0.3

Condensed Consolidated State_16

Condensed Consolidated Statements of Cash Flows Supplemental Information - Significant Non-cash Investing Activities - (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Net (decrease) increase in accruals related to:
Investment in equipment supporting joint revenue sharing arrangements		$ (469)	$ (764)
Acquisition of other intangible assets		5	(22)
Purchases of property, plant and equipment	[1]	78	548
Net accruals		$ (386)	$ (238)

[1] (1) Refer to Note 4 for supplemental disclosure of non-cash leasing activities.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Income Tax Contingency [Line Items]
Income tax expense (benefit)	$ 5,159	$ 4,885
Effective income tax rate	48.80%	48.80%
Canadian statutory income tax rate	26.50%	26.50%
Proposed share buyback tax	2%
Estimated amount of potential impact on buybacks tax	$ 400
Deferred tax liabilities	12,500		$ 12,500
Deferred income tax asset after valuation allowance	$ 7,700		$ 8,000

Capital Stock and Reserves - Ad

Capital Stock and Reserves - Additional Information (Details) $ / shares in Units, ¥ in Millions	1 Months Ended		3 Months Ended		12 Months Ended
	Jan. 31, 2024 USD ($) shares	Jan. 31, 2023 USD ($) shares	Mar. 31, 2024 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 shares	Dec. 31, 2022	Mar. 31, 2024 CNY (¥) shares	Jun. 06, 2023 shares	Jun. 23, 2022 shares	Jun. 12, 2017 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation costs recorded for the period \| $			$ 4,700,000	$ 5,100,000
Stock-based compensation expense \| $			$ 4,676,000	$ 5,059,000
Maximum number of shares of common stock may be issued for outstanding PSU			52,622,200		53,260,276		52,622,200
Common shares purchased in open market by trustee in connection with RSUs			0	0
Number of treasury shares held in trust for future settlement of share based awards			0		0
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units			3,824,411	4,260,382
Percentage of statutory net profits to statutory surplus reserve to be appropriated			10%				10%
Discontinuation of contribution, Aggregate sum of statutory surplus reserve more than its registered capital, percent			50%				50%
Statutory surplus reserve appropriated			$ 5,600,000				¥ 36.4
Statutory surplus reserve to its subsidiaries registered capital percent			50%				50%
Convertible Notes [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Debt instrument, initial conversion price \| $ / shares			$ 28.75
IMAX China
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Details of the share repurchase program			In 2022, IMAX China's shareholders granted its Board of Directors a general mandate authorizing the Board, subject to applicable laws, to repurchase shares of IMAX China not to exceed 10% of the total number of issued shares as of June 23, 2022 (34,063,480 shares). This program expired on the date of the 2023 Annual General Meeting of IMAX China on June 6, 2023. During the 2023 Annual General Meeting, shareholders approved the repurchase of shares of IMAX China not to exceed 10% of the total number of shares as of June 6, 2023 (33,959,314 shares). This program will be valid until the 2024 Annual General Meeting of IMAX China. The repurchases may be made in the open market or through other means permitted by applicable laws. IMAX China has no obligation to repurchase its shares and the share repurchase program may be suspended or discontinued by IMAX China at any time.
Stock Repurchase Program Expiration Date			Jun. 06, 2023			Jun. 23, 2022
Repurchase of common shares			0	0
Stock Repurchase Program, maximum percentage of shares to be repurchased								10%	10%
Stock Repurchase Program, Authorized number of shares								33,959,314	34,063,480
Parent [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Details of the share repurchase program			On June 12, 2017, the Company announced that its Board of Directors approved a $200.0 million share repurchase program for its common shares that would have expired on June 30, 2020, which was subsequently extended for a 12-month period in 2020, 2021, and 2023 and increased in the total share repurchase authority to $400.0 million. In 2023, the Company’s Board of Directors approved a 36-month extension to its share repurchase program through June 30, 2026. As of March 31, 2024, the Company has $150.8 million available under the program. The repurchases may be made either in the open market or through private transactions, including repurchases made pursuant to a plan intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, subject to market conditions, applicable legal requirements, and other relevant factors. The Company has no obligation to repurchase shares and the share repurchase program may be suspended or discontinued by the Company at any time.
Stock Repurchase Program, Authorized Amount \| $			$ 150,800,000							$ 200,000,000
Stock Repurchase Program Expiration Date			Jun. 30, 2020
Repurchase of common shares	108,393	140,000	1,158,724	109,477
Stock Acquired, Average Cost per Share \| $ / shares			$ 13.99	$ 14.87
Repurchase of common shares, value \| $	$ 1,600,000	$ 2,000,000	$ 16,200,000	$ 1,600,000
Parent [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount \| $			400,000,000
Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense \| $			$ 2,742,000	$ 3,365,000
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units			729,150	620,553
Restricted Share Units [Member] \| Non Employee [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense \| $				$ 0
Restricted Share Units [Member] \| Non Employee [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense \| $			$ 100,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense \| $				$ 84,000
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units			2,722,308	3,460,373
Performance Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense \| $			$ 1,852,000	$ 924,000
Stock based awards vesting period			3 years
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			175%
Antidilutive shares issuable upon exercise of stock options, restricted share units and performance stock units			372,953	179,456
Performance Stock Units [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			0%
Performance Stock Units [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage			175%
Performance Stock Units [Member] \| EBITDA
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage					150%	175%
Performance Stock Units [Member] \| EBITDA \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares of common stock may be issued for outstanding PSU			1,886,932				1,886,932

Capital Stock and Reserves - Sh

Capital Stock and Reserves - Share-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 4,676	$ 5,059
Costs and Expenses Applicable to Revenues [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	228	263
Selling, General and Administrative Expenses [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	4,337	5,196
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 111	99
Executive Transition Costs [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		$ (499)

Capital Stock and Reserves - St

Capital Stock and Reserves - Stock-based Compensation by Plan Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type	$ 4,676	$ 5,059
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type		84
Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type	2,742	3,365
Performance Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type	1,852	924
IMAX China Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type		10
IMAX China Long Term Incentive Plan Restricted Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type	27	541
IMAX China Long Term Incentive Plan Performance Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense by plan type	$ 55	$ 135

Capital Stock and Reserves - Sc

Capital Stock and Reserves - Schedule of Share-based Compensation, Stock Options, Activity (Details) - Stock Options [Member] - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding, beginning of period	3,329,422	3,604,739
Expired	(607,114)	(144,366)
Stock options outstanding, end of period	2,722,308	3,460,373
Stock options exercisable, end of period	2,722,308	3,460,373
Stock options outstanding, weighted average exercise price per share	$ 26.23	$ 26.36
Expired, weighted average exercise price per share	28.15	31.85
Stock options outstanding, weighted average exercise price per share	25.8	26.13
Stock options exercisable, weighted average exercise price per share, end of period	$ 25.8	$ 26.13

Capital Stock and Reserves - Re

Capital Stock and Reserves - Restricted Stock Units Activity under the IMAX LTIP (Details) - Restricted Share Units [Member] - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards outstanding, beginning of period	1,286,830	1,252,044
Granted	846,677	811,529
Vested and settled	(609,016)	(677,611)
Forfeited	(16,315)	(19,509)
Number of awards outstanding,end of period	1,508,176	1,366,453
Weighted average grant date fair value per share, beginning of period	$ 18.53	$ 19.16
Granted, weighted average grant date fair value per share	16.46	17.73
Vested and settled, weighted average grant date fair value per share	19.04	18.7
Forfeited, weighted average grant date fair value per share	19.12	19.8
Weighted average grant date fair value per share, end of period	$ 17.15	$ 18.53

Capital Stock and Reserves - Pe

Capital Stock and Reserves - Performance Stock Units Activity under the IMAX LTIP (Details) - Performance Stock Units [Member] - $ / shares		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of awards outstanding, beginning of period		922,621	931,716
Granted	[1]	578,855	580,118
Vested and settled	[1]	(316,226)	(368,602)
Forfeited	[2]	(78,489)	(208,648)
Number of awards outstanding,end of period		1,106,761	934,584
Weighted average grant date fair value per share, beginning of period		$ 19.16	$ 18.96
Granted, weighted average grant date fair value per share	[1]	17.98	17.68
Vested and settled, weighted average grant date fair value per share	[1]	19.71	16.92
Forfeited, weighted average grant date fair value per share	[2]	21.28	18.09
Weighted average grant date fair value per share, end of period		$ 18.32	$ 19.16

[1] For the three months ended March 31, 2024, the balance of shares granted includes 135,511 additional shares, at a weighted average grant date fair value per share of $ 19.71 , as PSUs granted in 2021 with Adjusted EBITDA targets vested at 175 % on account of full achievement of the targets. Forfeited PSUs include the TSR target awards issued in 2021 which did not vest as the market condition was not satisfied. For the three year period ending March 31, 2024, the Company recorded an expense of $ 1.5 million associated with these 68,850 shares which, despite the awards not vesting, will not be reversed into income.

Capital Stock and Reserves - _2

Capital Stock and Reserves - Performance Stock Units Activity under the IMAX LTIP (Parenthetical) (Details) - Performance Stock Units [Member] $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Additional shares granted	135,511
Additional shares granted, weighted average grant date fair value per share \| $ / shares	$ 19.71
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage	175%
Recorded expense \| $	$ 1.5
Shares not adjusted	68,850

Capital Stock and Reserves - Ba

Capital Stock and Reserves - Basic and Diluted Per-share Computations (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Equity [Abstract]
Issued and outstanding, beginning of period	53,260	54,149
Weighted average number of shares repurchased, net	(759)	(85)
Weighted average number of shares outstanding - basic	52,501	54,064
Weighted average effect of potential common shares, if dilutive	905	927
Weighted average number of shares outstanding - diluted	53,406	54,991

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Disaggregation of Revenue by Segment (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	[1]	$ 79,123	$ 86,946
Technology Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		7,904	17,822
Image Enhancement and Maintenance Services [Member]
Disaggregation of Revenue [Line Items]
Revenues		50,348	47,127
Technology Rentals [Member]
Disaggregation of Revenue [Line Items]
Revenues		18,601	20,058
Finance Income [Member]
Disaggregation of Revenue [Line Items]
Revenues		2,270	1,939
Content Solutions Segment Technology Products and Services Segment [Member]
Disaggregation of Revenue [Line Items]
Revenues		77,163	83,768
Content Solutions Segment Technology Products and Services Segment [Member] \| Technology Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		7,118	16,119
Content Solutions Segment Technology Products and Services Segment [Member] \| Image Enhancement and Maintenance Services [Member]
Disaggregation of Revenue [Line Items]
Revenues		49,174	45,652
Content Solutions Segment Technology Products and Services Segment [Member] \| Technology Rentals [Member]
Disaggregation of Revenue [Line Items]
Revenues		18,601	20,058
Content Solutions Segment Technology Products and Services Segment [Member] \| Finance Income [Member]
Disaggregation of Revenue [Line Items]
Revenues		2,270	1,939
All Other Segment [Member]
Disaggregation of Revenue [Line Items]
Revenues	[1]	1,960	3,178
All Other Segment [Member] \| Technology Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		786	1,703
All Other Segment [Member] \| Image Enhancement and Maintenance Services [Member]
Disaggregation of Revenue [Line Items]
Revenues		1,174	1,475
Operating Segments
Disaggregation of Revenue [Line Items]
Revenues	[1]	77,163	83,768
Operating Segments \| Content Solutions Segment [Member]
Disaggregation of Revenue [Line Items]
Revenues	[1]	34,013	32,101
Operating Segments \| Content Solutions Segment [Member] \| Film Remastering And Distribution [Member]
Disaggregation of Revenue [Line Items]
Revenues		29,721	30,073
Operating Segments \| Content Solutions Segment [Member] \| Other Content Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues		4,292	2,028
Operating Segments \| Content Solutions Segment [Member] \| Image Enhancement and Maintenance Services [Member]
Disaggregation of Revenue [Line Items]
Revenues		34,013	32,101
Operating Segments \| Content Solutions Segment [Member] \| Image Enhancement and Maintenance Services [Member] \| Film Remastering And Distribution [Member]
Disaggregation of Revenue [Line Items]
Revenues		29,721	30,073
Operating Segments \| Content Solutions Segment [Member] \| Image Enhancement and Maintenance Services [Member] \| Other Content Solutions [Member]
Disaggregation of Revenue [Line Items]
Revenues		4,292	2,028
Operating Segments \| Technology Products and Services Segment [Member]
Disaggregation of Revenue [Line Items]
Revenues	[1]	43,150	51,667
Operating Segments \| Technology Products and Services Segment [Member] \| System Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		7,118	16,119
Operating Segments \| Technology Products and Services Segment [Member] \| System Rentals [Member]
Disaggregation of Revenue [Line Items]
Revenues		18,601	20,058
Operating Segments \| Technology Products and Services Segment [Member] \| Maintenance [Member]
Disaggregation of Revenue [Line Items]
Revenues		15,161	13,551
Operating Segments \| Technology Products and Services Segment [Member] \| Technology Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		7,118	16,119
Operating Segments \| Technology Products and Services Segment [Member] \| Technology Sales [Member] \| System Sales [Member]
Disaggregation of Revenue [Line Items]
Revenues		7,118	16,119
Operating Segments \| Technology Products and Services Segment [Member] \| Image Enhancement and Maintenance Services [Member]
Disaggregation of Revenue [Line Items]
Revenues		15,161	13,551
Operating Segments \| Technology Products and Services Segment [Member] \| Image Enhancement and Maintenance Services [Member] \| Maintenance [Member]
Disaggregation of Revenue [Line Items]
Revenues		15,161	13,551
Operating Segments \| Technology Products and Services Segment [Member] \| Technology Rentals [Member]
Disaggregation of Revenue [Line Items]
Revenues		18,601	20,058
Operating Segments \| Technology Products and Services Segment [Member] \| Technology Rentals [Member] \| System Rentals [Member]
Disaggregation of Revenue [Line Items]
Revenues		18,601	20,058
Operating Segments \| Technology Products and Services Segment [Member] \| Finance Income [Member]
Disaggregation of Revenue [Line Items]
Revenues		$ 2,270	$ 1,939

[1] The Company’s largest customer represents 10 % of total Revenues for the three months ended March 31, 2024 (2023 — 9 %). No single customer comprises more than 10% of the Company’s total Accounts Receivable as of March 31, 2024 and December 31, 2023 .

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues earned	$ 79,123	$ 86,946
Deferred revenue earned	12,100	9,800
Revenues earned from leasing arrangements	19,300	22,400
Deferred revenue	60,999		$ 67,105	$ 70,900
Maintenance Services [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue Remaining Performance Obligation	20,900		$ 22,800
Revenues earned	50,348	47,127
Technology Sales [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues earned	7,904	17,822
Revenues earned from leasing arrangements	700	2,300
Technology Sales [Member] \| Variable Consideration Receivables [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues earned	1,700	5,600
Technology Rentals [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenues earned	18,601	6,578
Revenues earned from leasing arrangements	$ 18,600	$ 20,100

Segment Reporting - Additional

Segment Reporting - Additional Information (Details)	3 Months Ended
Segment Reporting - Additional Information (Details)	Mar. 31, 2024
Segment Reporting (Textual) [Abstract]
Disclosure on geographic areas, description of revenue from external customers	The United States and Greater China (which includes the mainland of the People’s Republic of China, Hong Kong, Macau, and Taiwan) each comprise greater than 10%

Segment Reporting - Segment Rep

Segment Reporting - Segment Reporting Information by Reportable Segment (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues
Revenue	[1]	$ 79,123	$ 86,946
Gross Margin
Gross Margin		46,889	50,051
All Other Segment [Member]
Revenues
Revenue	[1]	1,960	3,178
Gross Margin
Gross Margin		1,206	2,165
Operating Segments
Revenues
Revenue	[1]	77,163	83,768
Gross Margin
Gross Margin		45,683	47,886
Operating Segments \| Content Solutions
Revenues
Revenue	[1]	34,013	32,101
Gross Margin
Gross Margin		22,099	17,995
Operating Segments \| Technology Products and Services
Revenues
Revenue	[1]	43,150	51,667
Gross Margin
Gross Margin		$ 23,584	$ 29,891

[1] The Company’s largest customer represents 10 % of total Revenues for the three months ended March 31, 2024 (2023 — 9 %). No single customer comprises more than 10% of the Company’s total Accounts Receivable as of March 31, 2024 and December 31, 2023 .

Segment Reporting - Segment R_2

Segment Reporting - Segment Reporting Information by Reportable Segment (Parenthetical) (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Percentage of total revenues represented by largest customer	10%	9%

Segment Reporting - Summary of

Segment Reporting - Summary of Revenues By Geographic Area (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total	[1]	$ 79,123	$ 86,946
United States [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		26,604	26,753
Greater China [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		21,453	26,566
Western Europe [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		14,191	10,168
Asia (excluding Greater China) [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		9,126	10,652
Canada [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		2,408	7,196
Latin America [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		1,460	1,603
Rest of the World [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Revenues, total		$ 3,881	$ 4,008

[1] The Company’s largest customer represents 10 % of total Revenues for the three months ended March 31, 2024 (2023 — 9 %). No single customer comprises more than 10% of the Company’s total Accounts Receivable as of March 31, 2024 and December 31, 2023 .

Employee's Pension and Postreti

Employee's Pension and Postretirement Benefits - Additional Information (Details) - USD ($)		3 Months Ended
	Sep. 19, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Deferred Compensation Plan [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Deferred compensation plan description		The Company maintained a nonqualified deferred compensation benefit plan (the “Retirement Plan”) covering the former CEO of IMAX Entertainment and Senior Executive Vice President of the Company. Under the terms of the Retirement Plan, the benefits were due to vest in full if the executive incurred a separation from service from the Company (as defined therein).
Deferred Compensation Plan [Member] \| Accrued and Other Liabilities [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Benefit obligation recorded		$ 4,100,000		$ 4,100,000
Deferred Compensation Plan [Member] \| Prepaid Expenses [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Company-owned life insurance		$ 3,600,000		3,500,000
Richard L. Gelfond [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Benefit payable	$ 20,300,000
SERP Benefits [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Defined benefit pension plan		The Company has an unfunded defined benefit pension plan, the Supplemental Executive Retirement Plan (the “SERP”), covering its CEO, Richard L.
Benefit Obligation		$ 18,400,000		18,200,000
Companies contribution and expenses during the remainder of 2023		0
SERP Benefits [Member] \| Maximum [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Interest costs		200,000	$ 200,000
Expected additional interest costs in the remainder of the year		$ 600,000
Defined Contribution Plan [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Defined contribution pension plans for employees		The Company also maintains defined contribution plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums.
Maximum percentage of base salary contributed to Defined Contribution Pension Plan by Company		5%
Canadian Plan [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Contribution and recorded expense		$ 400,000	300,000
Us Internal Revenue Code [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Contribution and recorded expense		300,000	300,000
Postretirement Benefits Executives [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Benefit Obligation		500,000		500,000
Postretirement Benefits Executives [Member] \| Maximum [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Maximum amount of Postretirement benefit recorded expense		100,000	100,000
Postretirement Benefits Canadian Employees [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Benefit Obligation		800,000		$ 1,000,000
Postretirement Benefits Canadian Employees [Member] \| Maximum [Member]
Pension and Other Postretirement Benefit Expense (Textual) [Abstract]
Maximum amount of Postretirement benefit recorded expense		$ 100,000	$ 100,000

Financial Instruments - Additio

Financial Instruments - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) Country	Dec. 31, 2023 USD ($)
Financial Instruments (Textual) [Abstract]
Cash and cash equivalents	$ 81,017	$ 76,200
Cash held outside of Canada	$ 70,300	68,500
Number of countries that generate box office \| Country	89
Foreign Exchange contract settlement date range	settlement dates throughout 2024 and 2025
Estimated loss to be reclassified to earnings within the next twelve months	$ 100
Foreign Exchange Contract [Member] \| Designated as Hedging Instrument [Member]
Financial Instruments (Textual) [Abstract]
Notional value	34,820	40,563
Preferred Stock [Member] \| Other Assets [Member]
Financial Instruments (Textual) [Abstract]
Investment in equity securities - cost	1,000	1,000
China [Member]
Financial Instruments (Textual) [Abstract]
Cash held/undistributed earnings	$ 31,800	$ 30,000

Financial Instruments - Fair Va

Financial Instruments - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands		Mar. 31, 2024	Dec. 31, 2023
Other Financial Instrument
Cash and cash equivalents		$ 81,017	$ 76,200
Net investment in sales-type leases		29,323	29,539
Foreign exchange contracts forwards		(87)	819
Credit Facility borrowings		(68,034)	(22,924)
Carrying Amount, Fair Value Disclosure [Member] \| Fair Value, Inputs, Level 1 [Member]
Other Financial Instrument
Cash and cash equivalents	[1]	81,017	76,200
Carrying Amount, Fair Value Disclosure [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Net financed sales receivables	[2]	96,291	97,615
Net investment in sales-type leases	[2]	29,323	29,539
Equity securities	[1]	1,000	1,000
COLI	[3]	3,552	3,522
Convertible Notes	[4]	(230,000)	(230,000)
Carrying Amount, Fair Value Disclosure [Member] \| Wells Fargo Credit Facility [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Credit Facility borrowings	[1]	(69,000)	(24,000)
Carrying Amount, Fair Value Disclosure [Member] \| Designated as Hedging Instrument [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Foreign exchange contracts forwards	[5]	(87)	819
Carrying Amount, Fair Value Disclosure [Member] \| Federal Economic Development Loan [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Credit Facility borrowings	[2]	(2,426)	(2,498)
Estimate of Fair Value, Fair Value Disclosure [Member] \| Fair Value, Inputs, Level 1 [Member]
Other Financial Instrument
Cash and cash equivalents	[1]	81,017	76,200
Estimate of Fair Value, Fair Value Disclosure [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Net financed sales receivables	[2]	96,313	96,500
Net investment in sales-type leases	[2]	28,578	28,751
Equity securities	[1]	1,000	1,000
COLI	[3]	3,552	3,522
Convertible Notes	[4]	(213,571)	(205,850)
Estimate of Fair Value, Fair Value Disclosure [Member] \| Wells Fargo Credit Facility [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Credit Facility borrowings	[1]	(69,000)	(24,000)
Estimate of Fair Value, Fair Value Disclosure [Member] \| Designated as Hedging Instrument [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Foreign exchange contracts forwards	[5]	(87)	819
Estimate of Fair Value, Fair Value Disclosure [Member] \| Federal Economic Development Loan [Member] \| Fair Value, Inputs, Level 2 [Member]
Other Financial Instrument
Credit Facility borrowings	[2]	$ (2,426)	$ (2,498)

[1] Recorded at cost, which approximates fair value. Fair value is estimated based on discounting future cash flows at currently available interest rates with comparable terms. Measured at cash surrender value, which approximates fair value. Fair value is determined using quoted market prices that are observable in the market or that could be derived from observable market data. Fair value is determined using quoted prices in active markets.

Financial Instruments - Notiona

Financial Instruments - Notional Amount of Derivative (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Foreign Exchange Contract [Member] \| Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Foreign exchange contracts - Forwards	$ 34,820	$ 40,563

Financial Instruments - Fair _2

Financial Instruments - Fair Value of Foreign Exchange Contracts (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Derivatives Fair Value [Line Items]
Foreign exchange contracts - designated forwards	$ (87)	$ 819
Other Assets [Member] \| Designated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Foreign currency derivatives	104	846
Accrued and other liabilities [Member] \| Designated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Derivative Liability, Fair Value	$ (191)	$ (27)

Financial Instruments - Derivat

Financial Instruments - Derivatives in Foreign Currency Hedging Relationships (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments Gain Loss [Line Items]
Derivative (Loss) Gain Recognized in OCI (Effective Portion)	$ (916)	$ 134
Location of Derivative (Loss) Gain Reclassified from AOCI into Income (Effective Portion)	$ (11)	$ (339)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling, General and Administrative Expense	Selling, General and Administrative Expense
Fair Value Hedging [Member]
Derivative Instruments Gain Loss [Line Items]
Derivative (Loss) Gain Recognized in OCI (Effective Portion)	$ (916)	$ 134

Executive Transition Costs - Ad

Executive Transition Costs - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Executive Transition Costs [Abstract]
Executive transition costs	$ 0	$ 1,353,000

Non-Controlling Interests - Add

Non-Controlling Interests - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2014 USD ($) Film	Dec. 31, 2023 USD ($)
Redeemable Noncontrolling Interest [Line Items]
Non-controlling interests	$ 73,928			$ 71,790
Net income attributable to non-controlling interests	2,146	$ 2,669
Investment in film assets	$ 4,912	3,884
IMAX China Noncontrolling Interest
Redeemable Noncontrolling Interest [Line Items]
Minority Interest Ownership Percentage By Company	71.52%			71.55%
IMAX China
Redeemable Noncontrolling Interest [Line Items]
Non-controlling interests	$ 73,900			$ 71,800
Net income attributable to non-controlling interests	2,200	2,700
Other Noncontrolling Interest [Member]
Redeemable Noncontrolling Interest [Line Items]
Net income attributable to non-controlling interests	$ (9)	$ 9
Non-controlling interest description	The Company’s Original Film Fund was established in 2014 to co-finance a portfolio of 10 original large-format films. The initial investment in the Original Film Fund was committed by a third party in the amount of $25.0 million, with the possibility of contributing additional funds. The Company has contributed $9.0 million to the Original Film Fund since 2014 and has reached its maximum contribution.
Number of expected original films \| Film			10
Investment in film assets	$ 22,300
Other Noncontrolling Interest [Member] \| Third Party [Member]
Redeemable Noncontrolling Interest [Line Items]
Film fund committed capital contribution			$ 25,000
Other Noncontrolling Interest [Member] \| IMAX [Member]
Redeemable Noncontrolling Interest [Line Items]
Film fund contributions paid	$ 9,000

Non-Controlling Interests - Sum

Non-Controlling Interests - Summary of Movement of the Non-controlling Interest in Temporary Equity Related to Original Film Fund (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Non-controlling Interests
Net (loss) income	$ 2,146	$ 2,669
Other Noncontrolling Interest [Member]
Non-controlling Interests
Beginning Balance	658	722
Net (loss) income	(9)	9
Ending Balance	$ 649	$ 731

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ in Millions			2 Months Ended
	Feb. 28, 2024	Jan. 13, 2023	Mar. 31, 2024
Related Party Transaction [Line Items]
Aggregate amount of budget for documentary film		$ 2.6
Amount of budget agreed to be financed		$ 1.7
Percentage of remaining budget to be financed		75%
CICG
Related Party Transaction [Line Items]
Amount of budget agreed to be financed		$ 0.3
Percentage of budget agreed to be financed		10%
Beach House
Related Party Transaction [Line Items]
Amount of budget agreed to be financed		$ 0.6
Percentage of remaining budget to be financed		25%
Blue Ant
Related Party Transaction [Line Items]
Payment towards budget amount			$ 1
Blue Ant \| Beach House
Related Party Transaction [Line Items]
Percentage of ownership interest		70%
Sale of interest	100%